WO2014115479A1 - Stent, and stent-equipped prosthetic valve - Google Patents
Stent, and stent-equipped prosthetic valve Download PDFInfo
- Publication number
- WO2014115479A1 WO2014115479A1 PCT/JP2013/084891 JP2013084891W WO2014115479A1 WO 2014115479 A1 WO2014115479 A1 WO 2014115479A1 JP 2013084891 W JP2013084891 W JP 2013084891W WO 2014115479 A1 WO2014115479 A1 WO 2014115479A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- column
- valve
- axial direction
- members
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
Definitions
- the present invention relates to a stent and a prosthetic valve with a stent.
- a method for treating a diseased heart valve for example, an aortic valve
- a method for treating a diseased heart valve for example, an aortic valve
- an artificial heart valve artificial valve
- a delivery device such as a catheter
- Patent Document 1 discloses a method in which a prosthetic valve is integrated with a stent and delivered to a predetermined indwelling site.
- an artificial valve having a cylindrical portion and a plurality of valve membranes provided on the inner peripheral side of the cylindrical portion is used.
- the stent is formed into a tubular shape by a plurality of linear elements, extends in the axial direction and is provided at predetermined intervals in the circumferential direction, and a connecting portion that connects adjacent column portions to each other. Those having the following are used.
- the pillar portion has a pair of pillar members that extend in the axial direction and are arranged in the circumferential direction, and a plurality of connecting members that connect the respective pillar members, and the connecting portion is In the adjacent column members, the column members on the sides close to each other are connected to each other.
- the prosthetic valve is integrated with the stent by joining the cylindrical portion to each column portion of the stent by sewing or the like in a state where the cylindrical portion is arranged coaxially with the stent.
- each connecting material of the column portion extends in a direction orthogonal to the axial direction.
- the artificial valve placed in the body (specifically the valve membrane) opens and closes according to the heartbeat of the heart. Specifically, when the heart contracts and blood is pumped from the heart, the valve is pushed by the blood flow to open, while the heart relaxes and blood pumping is finished. The valve membrane closes and closes.
- the valve membrane is pressed and opened to the downstream side in the axial direction by the blood flow, so that a force directed toward the downstream side acts on the prosthetic valve.
- the blood that is going to flow back to the upstream side hits the valve membrane in the closed state, and the upstream valve acts on the artificial valve. That is, in the indwelling state of the artificial valve, a force in the axial direction acts on the artificial valve. Therefore, a force in the axial direction also acts on each column portion of the stent to which the artificial valve is joined.
- each valve membrane of the artificial valve is made of, for example, a living tissue, and its shape and size are not necessarily the same but are considered to be different from each other. The sizes may be different from each other. Then, it is considered that the axial force acting on the artificial valve is different in the circumferential direction, and consequently the magnitude of the axial force acting on each column portion of the stent is also different. In this case, it is assumed that the column parts try to be displaced from each other in the axial direction, and as a result, a tensile force in the axial direction is generated in each connection part that connects adjacent column parts.
- the connecting material that connects the column members extends in a direction orthogonal to the axial direction, and therefore exhibits sufficient resistance against the force in the axial direction. It seems difficult. For this reason, there is a possibility that the column portion may be deformed by causing a shift in the axial direction of each column material. In that case, it may be difficult to place the artificial valve in a stable state.
- the present invention has been made in view of the above circumstances, and has as its main object to provide a stent for an artificial valve and a prosthetic valve with a stent that allow the artificial valve to be stably placed in the body. Is.
- the stent of the first invention is formed into a tubular shape by a plurality of linear elements, and has a tubular portion and a plurality of valve membranes provided on the inner peripheral side of the tubular portion.
- a stent for a prosthetic valve for holding a forming portion, which extends in the axial direction of the stent, is disposed at a predetermined interval in the circumferential direction of the stent, and is integrated with the tubular portion, respectively.
- a plurality of pillars and a connecting part that connects the pillars adjacent to each other in the circumferential direction, and the pillars extend in the axial direction and are arranged in a row in the circumferential direction.
- Each of the pair of column members is connected to the different connecting portions in the circumferential direction, and the plurality of connection members are connected to each other.
- the material is inclined with respect to the axial direction
- a first oblique connecting member extending in a direction
- a second oblique connecting member extending obliquely opposite to the first oblique connecting member with respect to the axial direction
- an orthogonal connecting member extending in a direction orthogonal to the axial direction. At least any two of the materials are included.
- the diagonal connecting material (specifically, at least one of the first diagonal connecting material and the second diagonal connecting material) is included in the plurality of connecting materials connecting the column materials in the column portion. Since the diagonal connecting member extends in a direction inclined with respect to the axial direction, in other words, extends in a predetermined direction including a component in the axial direction, each column member of the column portion is connected to each column member. When the portion is pulled in a direction that causes a positional shift in the axial direction, a resistance force can be applied to the tensile force. Thereby, the position shift to the axial direction of each pillar material can be suppressed, and as a result, a deformation
- the stent of the second invention is characterized in that, in the first invention, the plurality of connecting materials include an orthogonal connecting material extending in a direction orthogonal to the axial direction in addition to the oblique connecting material. To do.
- the connecting material an orthogonal connecting material is provided in addition to the oblique connecting material.
- the strength of the pillar part can be suitably increased, and as a result, the deformation of the pillar part can be favorably suppressed.
- the stent of the third invention is characterized in that, in the second invention, the orthogonal connecting material is formed of a linear element thicker than the oblique connecting material.
- the shorter side of the orthogonal connecting material and the diagonal connecting material is provided.
- the orthogonal connecting material is formed with a linear element thicker than the oblique connecting material. In this case, it is possible to increase the strength of the column portion while suppressing an increase in the ratio of the connecting material between the column members, that is, suppressing a decrease in the gap between the connecting members.
- the stent of the 4th invention is the 2nd or 3rd invention.
- WHEREIN The connection location with the said connection part in one pillar material among each pillar material of the said pillar part, and the said connection part in the other pillar material The connection location is set at the same position in the axial direction, and the orthogonal connecting material is provided so as to connect the connection locations.
- the connecting portions respectively arranged between the pillar portions are arranged side by side in the circumferential direction.
- the connecting portions connected to the connecting portions in the column members of the column portions are in the same position in the axial direction. Therefore, in the present invention, in such a configuration, an orthogonal connecting member is provided so as to connect the connecting portions of the respective column members with the connecting portions.
- the adjacent connecting portions can be connected via the orthogonal connecting member with the pillar portion interposed therebetween, it is possible to suppress the displacement of the connecting portions.
- the stent according to a fifth aspect of the present invention is the stent according to any one of the first to fourth aspects, wherein the plurality of connecting members include any one of the first oblique connecting member, the second oblique connecting member, and the orthogonal connecting member.
- the plurality of connecting members include any one of the first oblique connecting member, the second oblique connecting member, and the orthogonal connecting member.
- a plurality of first linking materials and a plurality of second linking materials are included, and the first linking material and the second linking material are arranged so as to be alternately arranged in the axial direction. It is characterized by being continuous by being joined at the ends.
- the column portion can be extremely strengthened. Thereby, a deformation
- a stent of a sixth invention is characterized in that, in any one of the first to fifth inventions, the oblique connecting material is arranged so as not to cross each other connecting material.
- the diagonal connecting material and the other connecting material are arranged so as to cross each other, there is a possibility that the gap formed between the connecting materials between the column members becomes very small. In that case, it may be difficult to integrate the valve forming portion using the gap.
- the diagonal connecting material is arranged so as not to intersect with other connecting materials, it is possible to suppress the gap between them from becoming small, and the column using the gap can be suppressed. This is a convenient configuration for integrating the valve forming part with the part.
- a stent according to a seventh aspect is the stent according to any one of the first to sixth aspects, wherein the stent is formed of a material having radiopacity, and the stent is placed under X-ray projection on the column portion.
- the identification display part for discriminating whether the said pillar part is seen from the radial direction outer side and the inner side of the said stent is provided.
- each column part of the stent is provided side by side in the circumferential direction, when the stent is viewed under X-ray projection when the artificial valve is placed, the column part is arranged on the outer side (front side) and the inner side (back side) in the radial direction. It is assumed that it is difficult to determine from which side of Therefore, it is assumed that it is difficult to grasp the front and rear positions (specifically, the positions in the viewing direction) of the pillars in the body.
- the column portion is disposed at a position overlapping the inlet portion of the coronary artery in the vicinity of the aortic valve in the circumferential direction, and the column portion There is concern that the entrance may be blocked.
- the present invention in view of this point, it is possible to determine whether the column portion is viewed from the radially outer side or the inner side of the stent by providing the column with an identification display portion. I have to. In this case, when the artificial valve is indwelled, it becomes easy to grasp the front and rear positions of the column part, and it is possible to suppress or avoid the situation where the column part closes the inlet part of the coronary artery.
- An artificial valve with a stent according to an eighth invention is a prosthetic valve with a stent comprising the stent according to any one of the first to seventh inventions and the artificial valve held by the stent, wherein the valve forming part Is formed so that at least a part of the stent is embedded by a tissue of a living body, and is thereby integrated with the stent.
- the valve forming portion is formed so as to embed at least a part of the stent with a living tissue body, the stent is placed on the tube wall in the body while the artificial valve with the stent is placed in the body. Contact can be suppressed or prevented. Thereby, it is possible to suppress or prevent the occurrence of symptoms such as thrombosis.
- An artificial valve with a stent according to a ninth aspect of the present invention is a prosthetic valve with a stent comprising the stent according to any one of the first to seventh aspects of the invention and the valve forming part held by the stent, wherein the valve forming The portion is integrated with each column portion of the stent, and in the integrated state, each column portion is provided with an extending portion extending in the axial direction from the cylindrical portion. It is characterized by being.
- each column portion of the stent is provided with an extending portion extending in the axial direction from the tubular portion.
- the axial length of the stent column can be secured while keeping the axial length of the cylindrical portion short, so that the situation where the left coronary artery or the right coronary artery is blocked by the entrance is avoided. It becomes possible to place the artificial valve in a stable state.
- FIG. 1st Embodiment It is a perspective view which shows the artificial valve with a stent in 1st Embodiment, (a) has shown the valve closing state of the artificial valve, (b) has shown the valve opening state.
- FIG. 1 is a perspective view showing a prosthetic valve with a stent according to the present embodiment, in which (a) shows a closed state of the artificial valve, and (b) shows a valve open state.
- FIG. 2 is the front view which looked at the artificial valve with a stent from the axial direction.
- FIG. 3 is a perspective view of a stent constituting the prosthetic valve with a stent, and
- FIG. 4 is a developed view showing the expanded state of the stent.
- the stented artificial valve 10 (hereinafter simply referred to as the artificial valve 10) includes a stent 11 and a valve forming portion 12 held by the stent 11.
- the stent 11 is formed into a tubular shape (circular tubular shape) as a whole by a plurality of linear elements.
- the stent 11 is formed of a metal material that can be plastically deformed, and is specifically formed of a cobalt chromium alloy.
- the stent 11 can transition between a contracted state and an expanded state in which the outer diameter is larger than that by performing plastic deformation.
- FIGS. 3 and 4 both show the expanded state of the stent 11. Yes.
- the cobalt chromium alloy which is a forming material of the stent 11 is a material having a contrast function (X-ray opacity), and the stent 11 can be visually recognized under X-ray projection.
- the stent 11 is manufactured by laser-cutting a cylindrical body (tube) made of, for example, a cobalt chromium alloy.
- the stent 11 does not necessarily need to be formed with a cobalt chromium alloy, and may be formed with other metal materials, such as stainless steel and titanium.
- the stent 11 includes a plurality of (specifically three) column portions 14 extending in the axial direction and provided at predetermined intervals (specifically, equal intervals) in the circumferential direction, and column portions 14 adjacent to each other in the circumferential direction. And a plurality of connecting portions 15 connected to each other.
- the column portion 14 includes a pair of column members 17 provided in the axial direction and extending in the axial direction, and a plurality of connecting members 18 that connect the column members 17 to each other. Both the column member 17 and the connecting member 18 are formed of linear elements.
- the connecting portion 15 is formed in a wavy shape extending in the circumferential direction by a linear element, and has a shape that is alternately folded at both ends in the axial direction.
- the connection part 15 is arrange
- a plurality of connecting portions 15 are arranged at predetermined intervals (specifically, equally spaced) in the axial direction for each of the adjacent column portions 14, and three connecting portions 15 are arranged in this embodiment. Further, the positions (relationships) of the connecting portions 15 in the axial direction between the adjacent column portions 14 are the same between the column portions 14. Accordingly, when viewed in the circumferential direction, the plurality of connecting portions 15 are arranged along the same direction, and the rows of the plurality of connecting portions 15 arranged in the circumferential direction are provided over three rows. Yes. Note that the number of columns of the connecting portion 15 is not necessarily limited to three, and may be one, two, or four or more.
- All the connecting portions 15 have the same configuration and are arranged in the same direction. Both end portions of the connecting portion 15 in the circumferential direction correspond to the wavy line apex portion 15a of the connecting portion 15, and specifically correspond to the apex portion 15a on the same side in the axial direction. In this case, both end portions in the circumferential direction of the connecting portion 15 are positioned at the same position in the axial direction, and accordingly, the connecting portions with the column portions 14 at both ends of the connecting portion 15 are positioned at the same position in the axial direction. ing.
- each of the connection portions 15 adjacent to each other in the circumferential direction is connected to the pair of column members 17 with the column portion 14 interposed therebetween.
- the connection location with the connection part 15 in one pillar material 17 and the connection location with the connection part 15 in the other pillar material 17 are set to the same position in the axial direction.
- the column portion 14 is provided with a plurality of connecting members 18 that connect the pair of column members 17 to each other.
- the plurality of connecting members 18 are provided side by side in the axial direction (in other words, the longitudinal direction of the column member 17) between the pair of column members 17.
- the plurality of connecting members 18 include a first oblique connecting member 18a extending obliquely toward a predetermined side with respect to the axial direction (in other words, the longitudinal direction of the column member 17), and a first oblique connecting member 18a with respect to the axial direction.
- the 2nd diagonal joining material 18b which inclines in the opposite side and is extended, and the orthogonal joining material 18c extended in the direction orthogonal to an axial direction are contained.
- Each of the connecting members 18a to 18c is formed of a linear element having a substantially square cross section.
- the first diagonal connecting member 18a extends incline toward one side in the axial direction from one column member 17 to the other column member 17 between the respective column members 17, and the second diagonal connecting member 18b As it goes from the column member 17 to the other column member 17, the column member 17 is inclined to the other side in the axial direction.
- a plurality of first oblique connecting members 18a and a plurality of second oblique connecting members 18b are provided.
- the first diagonal connecting members 18a and the second diagonal connecting members 18b are arranged so as to be alternately arranged in the axial direction, and the adjacent first diagonal connecting members 18a and the second diagonal connecting members 18b are mutually end portions. It is connected with.
- the plurality of first oblique connecting members 18a and the plurality of second oblique connecting members 18b are continuous in a zigzag shape in the axial direction.
- the first diagonal connecting material 18a corresponds to the first connecting material
- the second diagonal connecting material 18b corresponds to the second connecting material.
- the diagonal connecting members 18 a and 18 b are disposed across the entire longitudinal direction of the column member 17 between the pair of column members 17.
- first diagonal connecting material 18a and second diagonal connecting material 18b are connected to the column member 17 at a connecting end portion 28 where the diagonal connecting materials 18a and 18b are connected to each other.
- the truss which consists of the 1st diagonal connection material 18a, the 2nd diagonal connection material 18b, and the pillar material 17 is formed continuously in the axial direction.
- the inclination angle ⁇ (specifically, the inclination angle ⁇ on the acute angle side) with respect to the axial direction of the first oblique connecting member 18a is set in a range of 30 ° to 60 °, and specifically, set to 45 °.
- the second oblique connecting member 18b also has an inclination angle ⁇ (specifically, an acute angle side inclination angle ⁇ ) in the range of 30 ° to 60 ° with respect to the axial direction, like the first oblique connecting member 18a. Specifically, it is set to 45 °. Therefore, in the present embodiment, the inclination angle ⁇ of the first oblique connecting member 18a and the inclination angle ⁇ of the second oblique connecting member 18b are respectively set to the same angle.
- the inclination angle ⁇ of the first oblique connecting member 18a and the inclination angle ⁇ of the second oblique connecting member 18b are not necessarily the same angle, and may be different angles.
- the inclination angle ⁇ of the first diagonal connecting member 18a may be different for each first diagonal connecting member 18a
- the inclination angle ⁇ of the second diagonal connecting member 18b may be different for each second diagonal connecting member 18b. It may be allowed.
- first diagonal connecting material 18a and the second diagonal connecting material 18b are each formed by linear elements having the same thickness. Accordingly, the line widths of the diagonal connecting members 18a and 18b are all the same line width D1, and in the present embodiment, the line width D1 is set to 0.254 mm. Note that the diagonal connecting members 18a and 18b are not necessarily formed by linear elements having the same thickness, and may be formed by linear elements having different thicknesses.
- a plurality of orthogonal connecting members 18c are provided at predetermined intervals in the axial direction between the pair of column members 17.
- the orthogonal connecting members 18c are respectively arranged between the connecting portions 15 adjacent in the circumferential direction with the column portion 14 interposed therebetween.
- the orthogonal connecting member 18 c connects the connecting portion of the one pillar member 17 with the connecting portion 15 and the connecting portion of the other pillar member 17 with the connecting portion 15 among the pillar members 17 of the pillar portion 14. Is provided.
- the orthogonal connecting member 18c is disposed at a boundary portion between the adjacent first oblique connecting member 18a and the second oblique connecting member 18b, and one end portion of the orthogonal connecting member 18c connects the oblique connecting members 18a and 18b. 28. Therefore, at the connection end portion 28, the four members of the first diagonal connecting member 18a, the second diagonal connecting member 18b, the orthogonal connecting member 18c, and the column member 17 are connected.
- the orthogonal connecting member 18c is formed of a linear element that is thicker than the oblique connecting members 18a and 18b. Therefore, the line width D2 of the orthogonal connecting member 18c is larger than the line width D1 of the oblique connecting members 18a and 18b, and is set to 0.439 mm in this embodiment.
- the orthogonal connecting material 18c is not necessarily formed by a linear element thicker than the oblique connecting materials 18a and 18b, and may be formed by a linear element thinner than the oblique connecting materials 18a and 18b, or the oblique connecting material 18a. , 18b may be formed by linear elements having the same thickness.
- a predetermined gap 23 is formed between the adjacent connecting members 18a to 18c between the pair of column members 17.
- the gap 23 is a portion into which a part of the valve forming portion 12 enters as will be described later.
- the column portion 14 is provided with a pair of end connecting members 18d and 18e as the connecting members 18.
- the end connecting member 18d connects one end portions of the column members 17 in the axial direction
- the end connecting member 18e connects the other end portions of the column members 17 in the axial direction.
- Each of the end connecting members 18d and 18e has an arc shape that is convex on the opposite side in the axial direction.
- Each pillar part 14 has the extension part 19 extended to the one side of an axial direction rather than the some connection part 15, respectively.
- the extension length of the extension part 19 is set to be the same as or larger than the interval (pitch) between the connecting parts 15 adjacent in the axial direction.
- each column portion 14 does not extend to the other side in the axial direction from the plurality of connecting portions 15.
- each column portion 14 has an end portion on the other side in the axial direction, the end portion on the other side in the plurality of connecting portions 15 (more specifically, the top portion on the other side in the connecting portion 15 on the other side). ).
- valve forming unit 12 will be described with reference to FIGS.
- the valve forming part 12 is formed of an animal tissue.
- the valve forming part 12 is formed of a human body, and specifically, is formed of a patient's own (self) tissue (that is, a self tissue). Therefore, the valve forming part 12 has excellent biocompatibility and blood compatibility.
- the valve forming portion 12 is formed so as to cover (embed) the entire stent 11, and thereby integrated with the stent 11.
- the valve forming portion 12 includes a cylindrical tubular portion 21 and a plurality (three in the present embodiment) of valve membranes 22 provided on the inner peripheral side of the tubular portion 21.
- the cylindrical portion 21 and each valve membrane 22 are integrally formed by the tissue body.
- the cylindrical portion 21 is disposed coaxially with the stent 11 (the center position is the same), and ranges from one end portion to the other end portion (in other words, the column portion 14) in the plurality of connecting portions 15 in the axial direction. In the entire region except for the extending portion 19).
- Each connecting portion 15 and each column portion 14 are embedded in the inside of the cylindrical portion 21, whereby the cylindrical portion 21 is integrated with each connecting portion 15 and each column portion 14.
- a part of the tissue body of the cylindrical portion 21 enters each gap 23 of the column portion 14, and the tissue body that enters the gap 23 corresponds to the column portion.
- the tissues covering 14 from both sides (front and back) are connected to each other. Therefore, the cylindrical portion 21 is in a state of being relatively firmly integrated with each column portion 14.
- the extending part 19 extends to one side in the axial direction from the cylindrical part 21, and is not embedded in the cylindrical part 21.
- the valve membrane 22 is a movable part that opens and closes in accordance with the pulsation of the heart.
- the valve membrane 22 When the heart contracts and blood is pumped from the heart, the valve membrane 22 is pushed by the blood flow to open the valve (FIG. 1). (See (b)).
- the valve When the heart relaxes and blood delivery from the heart ends, the valve is closed (see FIG. 1 (a)).
- the valve membrane 22 has a fan shape when viewed from the axial direction, and a plurality of the valve membranes 22 are arranged around the axial line of the cylindrical portion 21 (see FIG. 2).
- Each valve membrane 22 extends in a fan shape from the tubular portion 21 toward the inner peripheral side, and further toward one side in the axial direction (extending side of the extending portion 19) at the boundary portion with the adjacent valve membrane 22. It extends.
- a portion extending to the one side in the valve membrane 22 is an opening / closing portion 22a.
- the opening / closing portions 22 a of the respective valve membranes 22 are arranged to face each other, and the opening / closing portions 22 a come in contact with each other so that the valve membrane 22 is in a closed state and an opened state. It is designed to open and close.
- the opening / closing part 22a extends in the axial direction to the one side with respect to the tubular part 21, and more specifically, the extension length is substantially the same as the extension length of the extension part 19 in the column part 14. It has become.
- Each boundary between adjacent valve membranes 22 is located at the same position as each column 14 of the stent 11 in the circumferential direction.
- Each of the opening / closing portions 22a of the adjacent valve membranes 22 is joined to the extending portion 19 of the column portion 14 at its radially outer end.
- each opening / closing portion 22a is formed so as to cover the extending portion 19 at the end portion, and thereby integrated with the extending portion 19 (and thus the column portion 14).
- each valve membrane 22 has a shape recessed inward in the radial direction between adjacent column portions 14 (extension portions 19). Note that the tissue body also enters the gap 23 in the extended portion 19, and the tissue bodies on both sides of the extended portion 19 are connected to each other by the inserted tissue body.
- valve forming portion 12 of the present embodiment is integrated with the stent 11 without being sutured to the stent 11 at all. Further, the valve forming portion 12 does not include any artificial object, and is formed only by a human tissue.
- the expanded stent 11 is extrapolated and assembled to a mold (mold member) formed in accordance with the shape of the valve forming portion 12. Then, in this assembled state, the stent 11 is implanted into the patient's (self) body together with the mold. At this time, the stent 11 is embedded in a site having a certain size (volume) such as an abdominal cavity or an extremity. The stent 11 may be implanted subcutaneously.
- the tissue around the stent 11 starts to grow on the mold surface so as to cover the stent 11.
- the growth of the tissue progresses with time, and eventually the entire stent 11 is covered with the tissue. Thereafter, the stent 11 is taken out from the body together with the mold.
- the valve forming portion 12 is formed by cutting the tissue body formed in a state of covering the stent 11 or cutting unnecessary portions of the tissue body. Thereafter, the mold is pulled out from the stent 11. Thereby, manufacture of the artificial valve 10 is completed.
- FIGS. 5A and 5B are explanatory views for explaining a state in which the artificial valve 10 is placed in the body as a replacement valve for an aortic valve.
- FIG. 5A is a front view of the artificial valve 10 and FIG. It is a figure.
- the artificial valve 10 is transported to a predetermined indwelling site where the aortic valve is located using a balloon catheter.
- the balloon catheter has a balloon that can be inflated and deflated on the distal end side, as is well known.
- the artificial valve 10 is transported to the indwelling site while being mounted on the outer peripheral surface of the balloon in a deflated state.
- the artificial valve 10 is mounted on the balloon by the stent 11 being crimped onto the balloon to be in a contracted state. In this mounted state, a balloon is inserted inside the valve forming portion 12 (tubular portion 21) and the valve membrane 22 is opened.
- an approach for delivering the artificial valve 10 to a predetermined indwelling site having an aortic valve using a balloon catheter various approaches can be considered.
- an approach is conceivable in which a hole is provided in the lower wall of the left ventricle of the heart and the artificial valve 10 is introduced into the indwelling site through the hole through the left ventricle.
- a guide wire G is introduced to the ascending aorta BV1 (see FIG. 5A) in advance through the hole, and a balloon catheter on which the artificial valve 10 is mounted is introduced along the guide wire G.
- the artificial valve 10 on a balloon is conveyed to the indwelling site
- the balloon After transportation, the balloon is inflated by injecting a compressed fluid into the balloon, and the stent 11 (and thus the artificial valve 10) is deformed from the contracted state to the expanded state. Thereby, as shown in FIG. 5A, the artificial valve 10 is indwelled at a predetermined indwelling site in the expanded state of the stent 11. After the artificial valve 10 is placed, the balloon is deflated by extracting the compressed fluid injected into the balloon, and the balloon catheter is extracted from the body. Thereby, the indwelling work of the artificial valve 10 is completed.
- the prosthetic valve 10 is indwelled at a site where a diseased aortic valve BV3 is formed in Valsalva sinus V2.
- the prosthetic valve 10 is disposed in the inner part of the aortic valve BV3, and the aortic valve BV3 is swollen upward by the arrangement.
- an inlet of the left coronary artery BV4 and an inlet of the right coronary artery BV5 are provided above the aortic valve BV3 (downstream in the blood flow direction).
- the entrance portion of the left coronary artery BV4 and the entrance portion of the right coronary artery BV5 are positioned so as to face each other across the Valsalva sinus V2.
- the artificial valve 10 is indwelled in a state in which the extending portions 19 of the column portions 14 of the stent 11 face upward (in other words, the inlet portions of the coronary arteries BV4 and BV5).
- the artificial valve 10 is disposed such that the cylindrical portion 21 is located below the inlet portions of the coronary arteries BV4 and BV5.
- each column portion 14 does not overlap with the inlet portions of the coronary arteries BV4 and BV5 in the circumferential direction (see FIG. 5B).
- the entrance part of each coronary artery BV4, BV5 is obstruct
- FIG. Therefore, in the indwelling state of the artificial valve 10, the blood flow from the Valsalva sinus V2 into the coronary arteries BV4 and BV5 is not inhibited by the artificial valve 10.
- each column portion 14 does not overlap with the entrance portion of each coronary artery BV4, BV5
- the placement operation is performed while confirming the position of each column portion 14 under X-ray projection. It will be.
- the extension part 19 is provided in the column part 14 in the artificial valve 10, the axial direction length of the stent 11 (column part 14) can be reduced while keeping the axial direction length of the cylindrical part 21 short. It is possible to secure to some extent. For this reason, the artificial valve 10 can be placed in a stable state while avoiding a situation where the inlet portions of the coronary arteries BV4 and BV5 are blocked when the artificial valve 10 is placed.
- the first oblique connecting member 18 a extending obliquely with respect to the axial direction, and the first oblique connecting member 18 a with respect to the axial direction.
- a second oblique connecting member 18b extending inclined to the opposite side and an orthogonal connecting member 18c extending in a direction orthogonal to the axial direction were provided.
- the oblique connecting members 18a and 18b extend in a predetermined direction including a component in the axial direction.
- each column member 17 of the column portion 14 is pulled in a direction that causes a positional shift in the axial direction by a different connecting portion 15 connected to each column member 17, the tensile force is reduced. Resistance can be imparted. Thereby, position shift to the direction of an axis of each pillar material 17 can be controlled, and as a result, deformation of pillar part 14 can be controlled. Therefore, it becomes possible to place the artificial valve 10 in a stable state in the body.
- the orthogonal connecting member 18c having a shorter length was formed by a linear element thicker than the oblique connecting members 18a and 18b.
- the strength of the column portion 14 is increased while suppressing the proportion of the connecting material 18 occupying between the pair of column materials 17, that is, while suppressing the gap 23 between the connecting materials 18 from becoming small. Is possible.
- the connecting part with the connecting part 15 in one column member 17 and the connecting part with the connecting part 15 in the other column member 17 are set at the same position in the axial direction.
- an orthogonal connecting member 18c is provided so as to connect these connecting portions.
- the connecting portions 15 adjacent to each other with the pillar portion 14 interposed therebetween can be connected via the orthogonal connecting member 18c, so that the positional deviation between the connecting portions 15 can be suppressed.
- a plurality of first oblique joining members 18a and a plurality of second oblique joining members 18b are provided as the joining members 18, and the first oblique joining members 18a and the second oblique joining members 18b are alternately arranged in the axial direction. It was made to connect by connecting the edge parts of. In this case, since the truss by the 1st diagonal connection material 18a, the 2nd diagonal connection material 18b, and the column material 17 can be continuously formed in the axial direction in the column part 14, the column part 14 is made very strong. be able to. Thereby, a deformation
- the diagonal connecting members 18a and 18b are arranged so as not to cross each other connecting member 18, it is possible to avoid the gaps 23 formed between the column members 17 from being remarkably reduced. .
- the configuration is convenient when the valve forming portion 12 is integrated with the column portion 14 using the gap 23.
- valve forming portion 12 Since the valve forming portion 12 is formed so as to cover (embed) the entire stent 11 with a tissue of a human body, the stent 11 is prevented from directly contacting the tube wall in the body in a state where the artificial valve 10 is placed in the body. be able to. Thereby, it is possible to prevent the occurrence of symptoms such as thrombosis.
- FIG. 6 is a perspective view showing a stent in the present embodiment
- FIG. 7 is a development view showing the stent in a developed state. 6 and 7 each show an expanded state of the stent.
- the artificial valve 30 in the present embodiment includes a stent 31 and a valve forming portion 32 held by the stent 31. Since the valve formation part 32 is fundamentally the same structure as the valve formation part 12 in 1st Embodiment, detailed description is omitted here. Briefly, the valve forming part 32 is formed so as to cover the stent 31 with a human tissue like the valve forming part 12, and is provided on the inner peripheral side of the cylindrical part 33 and the cylindrical part 33. A plurality of valve membranes (not shown). In FIG. 7, for convenience, only the tubular portion 33 of the valve forming portion 32 is illustrated by a one-dot chain line.
- the stent 31 is formed into a tubular shape (circular tubular shape) as a whole by a plurality of linear elements.
- the stent 31 is formed of a metal material having elasticity, and specifically, is formed of a nickel titanium (Ni—Ti) alloy which is a kind of superelastic alloy.
- Ni—Ti nickel titanium
- the stent 31 is a so-called self-expanding stent that is deformed from a contracted state to an expanded state by its own elasticity.
- the stent 31 may be formed of another superelastic alloy such as an Au—Cd alloy, a Cu—Al—Ni alloy, or a Ni—Ti—Co alloy.
- the stent 31 extends in the axial direction and is arranged side by side in the circumferential direction, and a plurality of (specifically three) column portions 34 and a plurality of coupling portions 35 that couple the circumferential column portions 34 to each other. And a pair of holding portions 36 and 37 provided on both end sides of each column portion 34 in the axial direction.
- the column portion 34 includes a pair of column members 38 that extend in the axial direction and are arranged in the circumferential direction, and a plurality of connecting members 39 that connect the column members 38 to each other. Both the column member 38 and the connecting member 39 are formed of linear elements.
- the connecting portion 35 is formed in a wavy line extending in the circumferential direction by a linear element.
- the connecting portions 35 are respectively connected to the column members 38 on the sides close to each other in the circumferential direction in the column portions 34 whose both ends in the circumferential direction are adjacent to each other.
- the connection part 35 is arrange
- column of the connection part 35 does not necessarily need to be 1 row, and may be 2 or more rows.
- the holding portion 36 is provided at one end portion in the axial direction of each column portion 34, and the holding portion 37 is provided at the other end portion in the axial direction in each column portion 34.
- Each of the holding portions 36 and 37 is a portion that holds the stent 31 (and thus the artificial valve 30) by being pressed against the tube wall in the body when the artificial valve 30 is placed in the body.
- Each of the holding portions 36 and 37 is formed by a linear element.
- the holding portion 36 includes a connecting portion 41 that connects the end portions on one side in the axial direction of the column portions 34 adjacent in the circumferential direction.
- the connecting portion 41 connects the column members 38 on the sides close to each other in the circumferential direction in the adjacent column portions 34.
- the connecting portions 41 are respectively provided between adjacent column portions 34, and the connecting portions 41 are arranged side by side in the circumferential direction. 6 and 7, two connecting portions 41 are provided for each column portion 34, but may be provided one by one or three or more.
- Each connecting portion 41 extends to one side in the axial direction from the column portion 34 and has a folded shape that is folded to the other side at an end portion on one side.
- Each connecting portion 41 is formed so as to be displaced radially outward as it goes to the one side, and is located radially outside the column portion 34 at the end portion on the one side. Accordingly, the holding portion 36 has a flare shape that expands toward the end portion on the one side as a whole. In FIG. 6, for convenience, the holding unit 36 is illustrated in a state where it is not flare (the holding unit 37 is also the same).
- the holding portion 37 is provided on the other side in the axial direction with respect to each column portion 34 and each connecting portion 35, and has an annular shape (annular shape) around the axis of the stent 31 and has a wavy shape. .
- the holding portion 37 is connected to each column portion 34 and each connecting portion 35 via a linear intermediate member 43.
- the holding part 37 is formed so as to be displaced radially outward as it goes to the other side in the axial direction, and is located radially outside the column part 34 at the other end. Therefore, the holding portion 37 has a flare shape that expands toward the other end portion as a whole.
- only one holding portion 37 is provided, but a plurality (two or more) holding portions 37 may be provided at predetermined intervals in the axial direction. Further, the number of holding portions 37, the number of connecting portions 41, and the number of rows of connecting portions 35 may be arbitrarily set as long as the target expansion performance can be obtained in the stent 31.
- the column part 34 is provided with a plurality of oblique connecting members 39a extending obliquely to a predetermined side with respect to the axial direction and a plurality of orthogonal connecting members 39b extending in a direction orthogonal to the axial direction as connecting members 39. It has been.
- the oblique connecting members 39a and the orthogonal connecting members 39b are alternately arranged in the axial direction, and the adjacent oblique connecting members 39a and the orthogonal connecting members 39b are connected to each other at their ends. Thereby, the diagonal connecting material 39a and the orthogonal connecting material 39b are continuously zigzag in the axial direction.
- the adjacent diagonal connecting member 39a and the orthogonal connecting member 39b are connected to the column member 38 at the end portions where they are connected to each other.
- the truss by the diagonal connection material 39a, the orthogonal connection material 39b, and the pillar material 38 is formed continuously in the axial direction.
- the diagonal connecting material 39a corresponds to the first connecting material
- the orthogonal connecting material 39b corresponds to the second connecting material.
- the orthogonal connecting members 39b are respectively disposed between the connecting portions 35 adjacent in the circumferential direction with the pillar portion 34 interposed therebetween, and are respectively disposed between the connecting portions 41 adjacent in the circumferential direction with the pillar portion 34 interposed therebetween. ing. These orthogonal connecting members 39b are connected to the connecting portion 35 (41) in one column member 38 and the connecting portion 35 (41) in the other column member 38 among the column members 38 of the column portion 34. It is provided so that a connection location may be connected mutually. A predetermined gap 45 is formed between the connecting members 39a and 39b adjacent to each other between the pair of column members 38.
- the valve forming part 32 is arranged coaxially with the stent 31 with respect to the stent 31, and the cylindrical part 33 is formed so as to extend over the entire area of each column part 34 of the stent 31 in the axial direction.
- Each cylindrical portion 34 and each connecting portion 35 of the stent 31 are embedded in the cylindrical portion 33, and thereby the cylindrical portion 33 is integrated with each column portion 34 and each connecting portion 35.
- a part of the structure body of the cylindrical part 33 has entered each gap 45 of the column part 34, and the structure body that has entered the gap 45 has the column part 34 as its (front and back). Tissues covering each side are connected to each other. Therefore, the cylindrical portion 33 is relatively firmly integrated with each column portion 34.
- the holding portions 36 and 37 of the stent 31 are exposed from the cylindrical portion 33 on both sides in the axial direction.
- valve membrane of the valve forming portion 32 is arranged so that the boundary portion between adjacent valve membranes is located at the same position as each column portion 34 of the stent 31 in the circumferential direction. It is integrated with the column part 34 in the boundary part.
- FIG. 8 is an explanatory diagram for explaining a state in which the artificial valve 30 is placed in the body as a replacement valve for the aortic valve.
- the artificial valve 30 when transported to a predetermined indwelling site, it is transported using a dedicated delivery catheter.
- a delivery catheter is a double catheter structure composed of an inner tube and an outer tube.
- the artificial valve 30 is disposed in a contracted state of the stent 31 between the inner tube and the outer tube on the distal end side of the catheter, and the artificial valve 30 is transported to the indwelling site in the disposed state.
- the artificial valve 30 is removed from the outer tube by pulling the outer tube to the proximal side while restricting the movement of the artificial valve 30 to the proximal side with a stopper provided on the outer peripheral surface of the inner tube. Derived to the position side.
- the stent 31 is deformed from the contracted state to the expanded state by its own elasticity, and the artificial valve 30 is indwelled at the indwelling site in the stent expanded state.
- the artificial valve 30 is placed at a predetermined placement site in the Valsalva sinus V2 with the holding part 36 of the stent 31 on the upper side and the holding part 37 on the lower side.
- the artificial valve 30 is disposed such that the valve forming portion 32 (cylindrical portion 33) is located below the inlet portions of the coronary arteries BV4 and BV5, whereby the cylindrical portion 33 causes the inlets of the coronary arteries BV4 and BV5. It is avoided that the part is blocked.
- the holding portion 36 is pressed against the tube wall of the Valsalva sinus VB2 by its own elasticity, thereby holding the stent 31 and the artificial valve 30 in a stable state.
- an oblique connecting member 39a extending obliquely with respect to the axial direction, and an orthogonal connecting member 39b extending in a direction orthogonal to the axial direction, was provided.
- the diagonal connecting member 39a extends in a predetermined direction including a component in the axial direction. Therefore, when each column member 38 of the column part 34 is pulled in a direction that causes a positional shift in the axial direction by different connecting portions 35 and 41 connected to the respective column members 38, Resistance. Thereby, position shift to the axial direction of each pillar material 38 can be controlled, and as a result, deformation of pillar part 34 can be controlled. Therefore, it becomes possible to place the artificial valve 30 in a stable state in the body.
- the connecting material 39 since the orthogonal connecting material 39b is provided in addition to the oblique connecting material 39a, a large number of connecting materials 39 can be arranged between the column members 38 as compared with the case where only the oblique connecting material 39a is provided between the column members 38. it can. Therefore, the strength of the column part 34 can be suitably increased, and as a result, the deformation of the column part 34 can be suitably suppressed.
- connection part with the connection part 35 in one column member 38 and the connection part with the connection part 35 in the other column member 38 are set at the same position in the axial direction.
- an orthogonal connecting member 39b is provided so as to connect these connecting portions.
- the connecting portions 35 adjacent to each other with the pillar portion 34 interposed therebetween can be connected via the orthogonal connecting member 39b, so that the positional deviation between the connecting portions 35 can be suppressed.
- the effect of suppressing the displacement between the column members 38 to which the respective connecting portions 35 are connected can be enhanced, and as a result, the effect of suppressing the deformation of the column portions 34 can be enhanced.
- a plurality of oblique connecting members 39a and orthogonal connecting members 39b are provided as connecting members 39, and the oblique connecting members 39a and the orthogonal connecting members 39b are alternately arranged in the axial direction and connected to each other at the ends. It was continued with.
- the column portion 34 can be extremely strengthened. Thereby, a deformation
- the diagonal connecting members 39a are arranged so as not to intersect with the other connecting members 39, it is possible to avoid the gap 45 formed between the column members 38 from being remarkably reduced.
- the configuration is advantageous in integrating the valve forming portion 32 with the column portion 34 using the gap 45.
- the diagonal connecting members 18 a and 18 b may be provided as the connecting member 18 between the pair of pillar members 17. That is, the orthogonal connecting member 18c may be omitted. Also in this case, by providing the diagonal connecting members 18a and 18b, a resistance force can be applied to a tensile force that attempts to shift the position of each column member 17 in the axial direction. Therefore, the deformation of the column portion 14 can be suppressed, and the artificial valve 10 can be placed in a stable state.
- only the diagonal connecting material may be provided as the connecting material 39 between the pair of column members 38 in the same manner. That is, as the connecting material 39, only the oblique connecting material 39a and the oblique connecting material extending obliquely on the opposite side of the oblique connecting material 39a with respect to the axial direction may be provided.
- the diagonal connecting members 18a, 18b, 39a and the other connecting members 18, 39 are arranged so as to intersect each other, and the two are connected at the intersecting portion. May be.
- the adjacent connecting members 18 and 39 may be arranged apart from each other in the axial direction, and the connecting members 18 and 39 may be disconnected. In this case, since a relatively large gap 23 can be formed between the column members 17, it is even more convenient when the valve forming portion 12 is integrated using the gap 23.
- the valve forming portion 12 is formed so as to cover the entire stent 11, but may be formed so as to cover only a part of the stent 11. Even in that case, the stent 11 can be prevented from coming into contact with the tube wall in the body in the indwelling state of the artificial valve 10, and the occurrence of thrombosis can be suppressed.
- the valve forming part 12 does not necessarily have to be formed by its own tissue body, but may be formed by another person's tissue body.
- the stent 11 is embedded in another person's body, and the valve forming part 12 is formed around the stent 11.
- the stent 11 is implanted in the body of a different animal, and the valve forming portion 12 is formed around the stent 11. Examples of such heterologous animals include pigs, cows, goats, dogs, rabbits and the like.
- the valve forming portion 12 is integrally formed around the stent 11 by embedding the stent 11 in the body, but the valve forming portion 12 may be formed separately from the stent 11.
- the valve forming portion 12 it is conceivable to form a tissue body around the artificial body by embedding a cylindrical artificial body (for example, a mandrel) in the body of the living body, and to form a valve forming portion by the tissue body.
- the valve forming portion can be integrated with the stent 11 by sewing or the like to each column portion 14 of the stent 11 using the gap 23.
- valve forming part is not necessarily formed of a living body tissue, and may be formed of another material such as a polymer material. Also in that case, the valve forming portion can be integrated with the stent 11 by sewing or the like to each column portion 14.
- the stented prosthetic valve 10 of the present invention is used as a replacement valve for the aortic valve of the heart, but other valves (heart valves) provided in the heart, specifically, mitral valves, It can also be used as a replacement valve for tricuspid or pulmonary valve.
- the artificial valve of the present invention is not necessarily used as a replacement valve, and may be used as a vascular valve by being placed in a blood vessel, for example. In this case, efficient blood flow can be secured by suppressing the backflow of blood. Alternatively, it may be placed in a tube other than a blood vessel. For example, if it is placed in the esophagus, reflux esophagitis can be treated.
- Each column 14 is arranged in a direction that overlaps with the inlet portions of the coronary arteries BV4 and BV5 (that is, the direction shown in FIG. 9B), and the inlet portions are blocked by the extending portions 19 of the column portions 14. It is conceivable that a situation such as that occurred.
- the column portion 14 may be provided with an identification display unit for determining whether the column portion 14 is viewed from the radially inner side or the outer side of the stent 11. That is, the columnar portion 14 may be provided with an identification display portion that looks different when viewed from the outside in the radial direction and when viewed from the inside.
- an asymmetric marker having an asymmetric shape as the identification display unit.
- FIG. 10 shows a configuration in which a marker 48 made of a letter “G” is provided as an asymmetric marker on the extending portion 19 of the column portion 14.
- the marker 48 is provided so that it can be seen correctly when viewed from the outside in the radial direction. That is, it is provided so that the letter “G” appears to be reversed when viewed from the inside in the radial direction.
- the marker 48 may be provided at a portion other than the extending portion 19 in the column portion 14.
- the marker 48 on the front pillar portion 14A looks correct and is arranged in the orientation shown in FIG. 9B.
- the marker 48 on the front pillar portion 14A appears to be reversed.
- the artificial valve 10 is arranged in either the direction shown in FIG. 9A or the direction shown in FIG. 9B. It is possible to determine whether or not.
- the artificial valve 10 is indwelled, it is possible to avoid a situation where the inlet portions of the coronary arteries BV4 and BV5 are blocked by the column portion 14 (specifically, the extending portion 19).
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
The purpose of the present invention is to provide a stent for a prosthetic valve and a stent-equipped prosthetic valve, with which a prosthetic valve can be indwelled in a stable state inside a body. A stent-equipped prosthetic valve (10) is provided with a stent (11), and a valve forming part (12) held by the stent (11). The stent (11) is provided with: a plurality of column parts (14) which extend in an axial direction, and which are provided at a prescribed spacing in a peripheral direction; and coupling parts (15) with which adjacent column parts (14) in the peripheral direction are coupled to each other. The column parts (14) are each provided with: a pair of column members (17) which extend in the axial direction, and which are provided side by side in the peripheral direction; and a plurality of joining members (18) which join each of the column members (17) to the other. Different coupling parts (15) are coupled to each of the pair of column members (17) in the peripheral direction. The plurality of joining members (18) include: first oblique joining members (18a) which extend obliquely with respect to the axial direction; second oblique joining members (18b) which extend obliquely with respect to the axial direction towards an opposite side to that of the first oblique joining members (18a); and orthogonal joining members (18c) which extend in a direction orthogonal with respect to the axial direction.
Description
本発明は、ステント及びステント付き人工弁に関する。
The present invention relates to a stent and a prosthetic valve with a stent.
近年、疾患のある心臓弁(例えば大動脈弁)の治療法として、人工の心臓弁(人工弁)をカテーテル等の搬送器具を用いて心臓弁のある部位まで搬送し留置する方法が提案されている。この方法によれば、心臓弁手術により人工弁を疾患のある心臓弁に置換して留置する従来の外科的方法と比べ、患者への負担を大いに軽減させることができる。
In recent years, as a method for treating a diseased heart valve (for example, an aortic valve), a method has been proposed in which an artificial heart valve (artificial valve) is transported to a site where the heart valve is located using a delivery device such as a catheter. . According to this method, the burden on the patient can be greatly reduced as compared with a conventional surgical method in which a prosthetic valve is replaced with a diseased heart valve by heart valve surgery.
この種の経カテーテル的な心臓弁の治療法として、例えば特許文献1には、人工弁をステントと一体化させた状態で所定の留置部位へと搬送し留置する方法が開示されている。この場合、人工弁としては、筒状部とその筒状部の内周側に設けられる複数の弁膜とを有したものが用いられる。また、ステントとしては、複数の線状要素によって管状に形成されるとともに、軸線方向に延びかつ周方向に所定間隔で設けられた複数の柱部と、隣り合う柱部同士を互いに連結する連結部とを有したものが用いられる。より具体的には、柱部は、軸線方向に延びるとともに周方向に並んで配置された一対の柱材と、それら各柱材同士を繋ぐ複数の繋ぎ材とを有しており、連結部が隣り合う各柱材において互いに近い側の各柱材同士を連結している。そして、人工弁は、筒状部をステントと同軸に配置した状態で、当該筒状部をステントの各柱部に縫合等により接合することでステントと一体化されている。なお、柱部の各繋ぎ材は、軸線方向と直交する方向に延びている。
As this type of transcatheter heart valve treatment method, for example, Patent Document 1 discloses a method in which a prosthetic valve is integrated with a stent and delivered to a predetermined indwelling site. In this case, an artificial valve having a cylindrical portion and a plurality of valve membranes provided on the inner peripheral side of the cylindrical portion is used. In addition, the stent is formed into a tubular shape by a plurality of linear elements, extends in the axial direction and is provided at predetermined intervals in the circumferential direction, and a connecting portion that connects adjacent column portions to each other. Those having the following are used. More specifically, the pillar portion has a pair of pillar members that extend in the axial direction and are arranged in the circumferential direction, and a plurality of connecting members that connect the respective pillar members, and the connecting portion is In the adjacent column members, the column members on the sides close to each other are connected to each other. The prosthetic valve is integrated with the stent by joining the cylindrical portion to each column portion of the stent by sewing or the like in a state where the cylindrical portion is arranged coaxially with the stent. In addition, each connecting material of the column portion extends in a direction orthogonal to the axial direction.
体内に留置された人工弁(詳しくは弁膜)は心臓の心拍動に合わせて開閉する。具体的には、心臓が収縮して心臓から血液が送り出される際にはその血流によって弁膜が押されて開状態となるのに対し、心臓が弛緩して心臓からの血液の送り出しが終わると弁膜が閉じて閉状態になる。
The artificial valve placed in the body (specifically the valve membrane) opens and closes according to the heartbeat of the heart. Specifically, when the heart contracts and blood is pumped from the heart, the valve is pushed by the blood flow to open, while the heart relaxes and blood pumping is finished. The valve membrane closes and closes.
ところで、人工弁が開状態となる際には、弁膜が血流によって軸線方向の下流側に押圧されて開くことになるため、人工弁には下流側へ向けた力が作用することとなる。また、人工弁が閉状態にある際には、上流側へと逆流しようとする血液が閉状態の弁膜に当たり、人工弁には上流側への力が作用することとなる。つまり、人工弁の留置状態では、人工弁に軸線方向への力が作用することとなる。したがって、人工弁が接合されているステントの各柱部にもそれぞれ軸線方向への力が作用することとなる。
By the way, when the prosthetic valve is in the open state, the valve membrane is pressed and opened to the downstream side in the axial direction by the blood flow, so that a force directed toward the downstream side acts on the prosthetic valve. Further, when the artificial valve is in the closed state, the blood that is going to flow back to the upstream side hits the valve membrane in the closed state, and the upstream valve acts on the artificial valve. That is, in the indwelling state of the artificial valve, a force in the axial direction acts on the artificial valve. Therefore, a force in the axial direction also acts on each column portion of the stent to which the artificial valve is joined.
この点に関してより具体的には、人工弁の各弁膜は例えば生体組織よりなり、その形状や大きさが必ずしも同じではなく互いに異なっていると考えられるため、各弁膜が血流によってそれぞれ受ける力の大きさは互いに異なることが考えられる。そうすると、人工弁に作用する軸線方向の力は周方向において異なることが考えられ、ひいてはステントの各柱部に作用する軸線方向の力の大きさも互いに異なることが考えられる。この場合、各柱部は互いに軸線方向へ位置ずれしようとし、その結果隣り合う柱部を連結する各連結部にはそれぞれ軸線方向への引張力が生じることが想定される。
More specifically in this regard, each valve membrane of the artificial valve is made of, for example, a living tissue, and its shape and size are not necessarily the same but are considered to be different from each other. The sizes may be different from each other. Then, it is considered that the axial force acting on the artificial valve is different in the circumferential direction, and consequently the magnitude of the axial force acting on each column portion of the stent is also different. In this case, it is assumed that the column parts try to be displaced from each other in the axial direction, and as a result, a tensile force in the axial direction is generated in each connection part that connects adjacent column parts.
ここで、隣り合う柱部における互いに近い側の柱材同士が連結部によって連結される特許文献1の構成では、柱部の一対の各柱材にそれぞれ周方向において異なる連結部が連結されている。したがって、上記したように連結部に軸線方向への引張力が生じた場合に、柱部の各柱材がそれぞれ異なる連結部によって、軸線方向への位置ずれを生じさせる向きに引っ張られることが想定される。
Here, in the configuration of Patent Document 1 in which the column members on the side close to each other in the adjacent column portions are connected by the connection portion, different connection portions are connected to the pair of column materials of the column portion in the circumferential direction. . Therefore, when a tensile force in the axial direction is generated in the connecting portion as described above, it is assumed that each column material of the column portion is pulled by a different connecting portion in a direction that causes a positional shift in the axial direction. Is done.
この点上記特許文献1のステントでは、柱材同士を繋ぐ繋ぎ材が軸線方向に対して直交する方向に延びているため、かかる軸線方向への力に対して十分な抵抗力を発揮するのが難しいと考えられる。そのため、各柱材の軸線方向へのずれを招いて柱部に変形が生じてしまうおそれがある。その場合、人工弁を安定した状態で留置することが困難になるおそれがある。
In this respect, in the stent of Patent Document 1 described above, the connecting material that connects the column members extends in a direction orthogonal to the axial direction, and therefore exhibits sufficient resistance against the force in the axial direction. It seems difficult. For this reason, there is a possibility that the column portion may be deformed by causing a shift in the axial direction of each column material. In that case, it may be difficult to place the artificial valve in a stable state.
本発明は、上記事情に鑑みてなされたものであり、体内において人工弁を安定した状態で留置することを可能とする人工弁用のステント及びステント付き人工弁を提供することを主たる目的とするものである。
The present invention has been made in view of the above circumstances, and has as its main object to provide a stent for an artificial valve and a prosthetic valve with a stent that allow the artificial valve to be stably placed in the body. Is.
上記課題を解決すべく、第1の発明のステントは、複数の線状要素によって管状に形成されるとともに、筒状部と該筒状部の内周側に設けられる複数の弁膜とを有する弁形成部を保持するための人工弁用のステントであって、当該ステントの軸線方向に延びるとともに当該ステントの周方向に所定の間隔で配設され、かつ、前記筒状部とそれぞれ一体化される複数の柱部と、前記周方向に隣り合う前記柱部同士を互いに連結する連結部と、を備え、前記柱部は、前記軸線方向に延びるとともに前記周方向に並んで設けられた一対の柱材と、それら各柱材同士を繋ぐ複数の繋ぎ材と、を有しており、前記一対の柱材のそれぞれには、前記周方向において異なる前記連結部が連結されており、前記複数の繋ぎ材には、前記軸線方向に対して傾斜して延びる第1斜め繋ぎ材と、前記軸線方向に対して前記第1斜め繋ぎ材とは逆側に傾斜して延びる第2斜め繋ぎ材と、前記軸線方向に対して直交する方向に延びる直交繋ぎ材とのうち少なくともいずれか2つが含まれていることを特徴とする。
In order to solve the above-mentioned problem, the stent of the first invention is formed into a tubular shape by a plurality of linear elements, and has a tubular portion and a plurality of valve membranes provided on the inner peripheral side of the tubular portion. A stent for a prosthetic valve for holding a forming portion, which extends in the axial direction of the stent, is disposed at a predetermined interval in the circumferential direction of the stent, and is integrated with the tubular portion, respectively. A plurality of pillars and a connecting part that connects the pillars adjacent to each other in the circumferential direction, and the pillars extend in the axial direction and are arranged in a row in the circumferential direction. Each of the pair of column members is connected to the different connecting portions in the circumferential direction, and the plurality of connection members are connected to each other. The material is inclined with respect to the axial direction A first oblique connecting member extending in a direction, a second oblique connecting member extending obliquely opposite to the first oblique connecting member with respect to the axial direction, and an orthogonal connecting member extending in a direction orthogonal to the axial direction. At least any two of the materials are included.
本発明によれば、柱部において各柱材を繋ぐ複数の繋ぎ材に少なくとも斜め繋ぎ材(詳しくは第1斜め繋ぎ材及び第2斜め繋ぎ材の少なくともいずれか)が含まれている。斜め繋ぎ材は、軸線方向に対して傾斜する方向に延び、換言すると軸線方向への成分を含む所定方向に延びているため、柱部の各柱材が各々の柱材に連結された異なる連結部により、軸線方向への位置ずれを生じさせる向きに引っ張られた場合に、その引張力に対して抵抗力を付与することができる。これにより、各柱材の軸線方向への位置ずれを抑制することができ、その結果柱部の変形を抑制することができる。したがって、体内においてステント付き人工弁を安定した状態で留置することが可能となる。
According to the present invention, at least the diagonal connecting material (specifically, at least one of the first diagonal connecting material and the second diagonal connecting material) is included in the plurality of connecting materials connecting the column materials in the column portion. Since the diagonal connecting member extends in a direction inclined with respect to the axial direction, in other words, extends in a predetermined direction including a component in the axial direction, each column member of the column portion is connected to each column member. When the portion is pulled in a direction that causes a positional shift in the axial direction, a resistance force can be applied to the tensile force. Thereby, the position shift to the axial direction of each pillar material can be suppressed, and as a result, a deformation | transformation of a column part can be suppressed. Therefore, the stented artificial valve can be placed in a stable state in the body.
第2の発明のステントは、第1の発明において、前記複数の繋ぎ材には、前記斜め繋ぎ材に加え、前記軸線方向と直交する方向に延びる直交繋ぎ材が含まれていることを特徴とする。
The stent of the second invention is characterized in that, in the first invention, the plurality of connecting materials include an orthogonal connecting material extending in a direction orthogonal to the axial direction in addition to the oblique connecting material. To do.
柱部の変形を抑制する上では、一対の柱材間に、繋ぎ材として斜め繋ぎ材を数多く配置することが望ましいが、斜め繋ぎ材は、柱材間にそれ程多く配置することはできない。そこで本発明では、繋ぎ材として、斜め繋ぎ材に加え直交繋ぎ材を設けるようにしている。この場合、柱材間に斜め繋ぎ材のみを設ける場合と比べ、柱材間に繋ぎ材を数多く配置することができる。そのため、柱部の強度を好適に高めることができ、その結果柱部の変形を好適に抑制することが可能となる。
In order to suppress the deformation of the column part, it is desirable to arrange a large number of diagonal connecting materials as connecting materials between a pair of column materials, but the diagonal connecting materials cannot be arranged so much between the column materials. Therefore, in the present invention, as the connecting material, an orthogonal connecting material is provided in addition to the oblique connecting material. In this case, it is possible to arrange a large number of connecting materials between the column members as compared with the case where only the oblique connecting materials are provided between the column members. Therefore, the strength of the pillar part can be suitably increased, and as a result, the deformation of the pillar part can be favorably suppressed.
第3の発明のステントは、第2の発明において、前記直交繋ぎ材は、前記斜め繋ぎ材よりも太い線状要素により形成されていることを特徴とする。
The stent of the third invention is characterized in that, in the second invention, the orthogonal connecting material is formed of a linear element thicker than the oblique connecting material.
柱部の変形を抑制する上では、繋ぎ材を太い線状要素によって形成し柱部の強度を高めることが望ましい。しかしながら、繋ぎ材を太くすると、柱材間において繋ぎ材が占める割合が大きくなり、柱材間において繋ぎ材同士の間に形成される隙間の大きさが小さくなってしまう。そうすると、かかる隙間を利用して弁形成部を柱部に一体化させる際不都合となる。例えば、弁形成部を一部隙間に通すことで柱部と一体化させる際、あるいは弁形成部を隙間を利用して柱部に縫合し一体化させる際等に不都合が生じる。
In order to suppress the deformation of the column part, it is desirable to increase the strength of the column part by forming the connecting material with a thick linear element. However, if the connecting material is thickened, the proportion of the connecting material between the column members increases, and the size of the gap formed between the connecting materials between the column members decreases. If it does so, it will become inconvenient when integrating a valve formation part in a pillar part using this crevice. For example, inconvenience occurs when the valve forming portion is partially integrated with the column portion through the gap, or when the valve forming portion is stitched and integrated with the column portion using the gap.
そこで本発明では、この点に鑑みて、繋ぎ材として斜め繋ぎ材と直交繋ぎ材との双方を設ける上記第2の発明において、それら直交繋ぎ材と斜め繋ぎ材とのうち、長さが短い側の直交繋ぎ材について、斜め繋ぎ材よりも太い線状要素により形成するようにしている。この場合、柱材間において繋ぎ材が占める割合が大きくなるのを抑制しながら、すなわち繋ぎ材同士の隙間が小さくなるのを抑制しながら、柱部の強度を高めることができる。
Therefore, in the present invention, in view of this point, in the second invention in which both the diagonal connecting material and the orthogonal connecting material are provided as the connecting material, the shorter side of the orthogonal connecting material and the diagonal connecting material is provided. The orthogonal connecting material is formed with a linear element thicker than the oblique connecting material. In this case, it is possible to increase the strength of the column portion while suppressing an increase in the ratio of the connecting material between the column members, that is, suppressing a decrease in the gap between the connecting members.
第4の発明のステントは、第2又は第3の発明において、前記柱部の各柱材のうち一方の柱材における前記連結部との連結箇所と、他方の柱材における前記連結部との連結箇所とは前記軸線方向において同位置に設定されており、前記直交繋ぎ材は、それら各連結箇所を繋ぐように設けられていることを特徴とする。
The stent of the 4th invention is the 2nd or 3rd invention. WHEREIN: The connection location with the said connection part in one pillar material among each pillar material of the said pillar part, and the said connection part in the other pillar material The connection location is set at the same position in the axial direction, and the orthogonal connecting material is provided so as to connect the connection locations.
この種のステントでは、各柱部間ごとにそれぞれ配設される各連結部が周方向に並んで配置されることが考えられる。この場合、柱部の各柱材においてそれぞれ連結部と連結される互いの連結箇所が軸線方向で同位置になることが考えられる。そこで本発明では、かかる構成において、それら各柱材における連結部との連結箇所同士を繋ぐように直交繋ぎ材を設けるようにしている。この場合、柱部を挟んで隣り合う連結部同士を直交繋ぎ材を介して繋ぐことができるため、それら連結部同士の位置ずれを抑制することができる。その結果、各連結部が連結された柱材同士の位置ずれ抑制効果を高めることができ、ひいては柱部の変形を抑制する効果を高めることができる。
In this type of stent, it is conceivable that the connecting portions respectively arranged between the pillar portions are arranged side by side in the circumferential direction. In this case, it is conceivable that the connecting portions connected to the connecting portions in the column members of the column portions are in the same position in the axial direction. Therefore, in the present invention, in such a configuration, an orthogonal connecting member is provided so as to connect the connecting portions of the respective column members with the connecting portions. In this case, since the adjacent connecting portions can be connected via the orthogonal connecting member with the pillar portion interposed therebetween, it is possible to suppress the displacement of the connecting portions. As a result, it is possible to increase the effect of suppressing the displacement between the column members to which the respective connecting portions are connected, and consequently to increase the effect of suppressing the deformation of the column portions.
第5の発明のステントは、第1乃至第4のいずれかの発明において、前記複数の繋ぎ材には、前記第1斜め繋ぎ材、前記第2斜め繋ぎ材及び前記直交繋ぎ材のうちのいずれか2つである第1繋ぎ材及び第2繋ぎ材がそれぞれ複数ずつ含まれており、前記第1繋ぎ材と前記第2繋ぎ材とはそれぞれ前記軸線方向に交互に並ぶように配置され、互いの端部同士で接合されることにより連続していることを特徴とする。
The stent according to a fifth aspect of the present invention is the stent according to any one of the first to fourth aspects, wherein the plurality of connecting members include any one of the first oblique connecting member, the second oblique connecting member, and the orthogonal connecting member. A plurality of first linking materials and a plurality of second linking materials are included, and the first linking material and the second linking material are arranged so as to be alternately arranged in the axial direction. It is characterized by being continuous by being joined at the ends.
本発明によれば、柱部において、第1繋ぎ材と第2繋ぎ材と柱材とによるトラスを軸線方向に連続して形成することができるため、柱部を極めて強固にすることができる。これにより、柱部の変形を顕著に抑制することができ、人工弁の留置状態を著しく安定なものとすることができる。
According to the present invention, since the truss made of the first connecting material, the second connecting material, and the column material can be continuously formed in the axial direction in the column portion, the column portion can be extremely strengthened. Thereby, a deformation | transformation of a pillar part can be suppressed notably and the indwelling state of an artificial valve can be made extremely stable.
第6の発明のステントは、第1乃至第5のいずれかの発明において、前記斜め繋ぎ材は、他の繋ぎ材と互いに交差しないように配置されていることを特徴とする。
A stent of a sixth invention is characterized in that, in any one of the first to fifth inventions, the oblique connecting material is arranged so as not to cross each other connecting material.
斜め繋ぎ材と他の繋ぎ材とが互いに交差して配置される構成では、各柱材間において繋ぎ材同士の間に形成される隙間が非常に小さなものとなってしまうおそれがある。その場合、隙間を利用して弁形成部を一体化させるのが困難になってしまうおそれがある。その点本発明では、斜め繋ぎ材を他の繋ぎ材と互いに交差しないように配置しているため、それら両者間の隙間が小さくなってしまうのを抑制することができ、隙間を利用して柱部に弁形成部を一体化させる上で好都合な構成となる。
In the configuration in which the diagonal connecting material and the other connecting material are arranged so as to cross each other, there is a possibility that the gap formed between the connecting materials between the column members becomes very small. In that case, it may be difficult to integrate the valve forming portion using the gap. In that respect, in the present invention, since the diagonal connecting material is arranged so as not to intersect with other connecting materials, it is possible to suppress the gap between them from becoming small, and the column using the gap can be suppressed. This is a convenient configuration for integrating the valve forming part with the part.
第7の発明のステントは、第1乃至第6のいずれかの発明において、X線不透過性を有する材料により形成されているステントであり、前記柱部には、前記ステントをX線投影下にて視認するに際し、当該柱部を前記ステントの径方向外側及び内側のうちいずれの側から見ているのかを判別するための識別表示部が設けられていることを特徴とする。
A stent according to a seventh aspect is the stent according to any one of the first to sixth aspects, wherein the stent is formed of a material having radiopacity, and the stent is placed under X-ray projection on the column portion. When visually recognizing, the identification display part for discriminating whether the said pillar part is seen from the radial direction outer side and the inner side of the said stent is provided.
ところで、ステントの各柱部は周方向に並んで設けられているため、人工弁の留置に際しステントをX線投影下で視認する場合に、柱部を径方向の外側(表側)及び内側(裏側)のうちいずれの側から見ているのかを判別しにくいことが想定される。そのため、体内における柱部の前後位置(詳細には視認方向における位置)が把握しづらいことが想定される。したがって、例えば人工弁を大動脈弁の置換弁として体内に留置する場合に、柱部が大動脈弁付近にある冠動脈の入口部と周方向にて重複する位置に配置されてしまい、その柱部により当該入口部を塞いでしまうといった事態が生じることが懸念される。
By the way, since each column part of the stent is provided side by side in the circumferential direction, when the stent is viewed under X-ray projection when the artificial valve is placed, the column part is arranged on the outer side (front side) and the inner side (back side) in the radial direction. It is assumed that it is difficult to determine from which side of Therefore, it is assumed that it is difficult to grasp the front and rear positions (specifically, the positions in the viewing direction) of the pillars in the body. Therefore, for example, when an artificial valve is placed in the body as a replacement valve for an aortic valve, the column portion is disposed at a position overlapping the inlet portion of the coronary artery in the vicinity of the aortic valve in the circumferential direction, and the column portion There is concern that the entrance may be blocked.
そこで本発明では、この点に鑑みて、柱部に識別表示部を設け、その識別表示部により当該柱部をステントの径方向外側及び内側のうちいずれの側から見ているのかを判別できるようにしている。この場合、人工弁の留置に際し、柱部の前後位置が把握し易くなり、柱部によって冠動脈の入口部を塞いでしまう事態が生じるのを抑制又は回避することが可能となる。
Therefore, in the present invention, in view of this point, it is possible to determine whether the column portion is viewed from the radially outer side or the inner side of the stent by providing the column with an identification display portion. I have to. In this case, when the artificial valve is indwelled, it becomes easy to grasp the front and rear positions of the column part, and it is possible to suppress or avoid the situation where the column part closes the inlet part of the coronary artery.
第8の発明のステント付き人工弁は、第1乃至第7のいずれかの発明のステントと、前記ステントによって保持された前記人工弁と、を備えるステント付き人工弁であって、前記弁形成部は、生体の組織体によって前記ステントの少なくとも一部を埋設させるように形成されており、それによって前記ステントと一体化されていることを特徴とする。
An artificial valve with a stent according to an eighth invention is a prosthetic valve with a stent comprising the stent according to any one of the first to seventh inventions and the artificial valve held by the stent, wherein the valve forming part Is formed so that at least a part of the stent is embedded by a tissue of a living body, and is thereby integrated with the stent.
本発明によれば、弁形成部が生体の組織体によってステントの少なくとも一部を埋設させるように形成されているため、ステント付き人工弁を体内に留置した状態で、ステントが体内の管壁に接触するのを抑制又は防止することができる。これにより、血栓症等の症状が発生するのを抑制又は防止することができる。
According to the present invention, since the valve forming portion is formed so as to embed at least a part of the stent with a living tissue body, the stent is placed on the tube wall in the body while the artificial valve with the stent is placed in the body. Contact can be suppressed or prevented. Thereby, it is possible to suppress or prevent the occurrence of symptoms such as thrombosis.
第9の発明のステント付き人工弁は、第1乃至第7のいずれかの発明のステントと、前記ステントによって保持された前記弁形成部と、を備えるステント付き人工弁であって、前記弁形成部は、前記ステントの各柱部に対して一体化されており、その一体化状態において前記各柱部にはそれぞれ前記筒状部よりも前記軸線方向に延出した延出部が設けられていることを特徴とする。
An artificial valve with a stent according to a ninth aspect of the present invention is a prosthetic valve with a stent comprising the stent according to any one of the first to seventh aspects of the invention and the valve forming part held by the stent, wherein the valve forming The portion is integrated with each column portion of the stent, and in the integrated state, each column portion is provided with an extending portion extending in the axial direction from the cylindrical portion. It is characterized by being.
ところで、体内において心臓の大動脈弁周辺には左冠動脈や右冠動脈の入口部が存在している。したがって、ステント付き人工弁を大動脈弁の置換弁として体内に留置する場合、当該人工弁の軸線方向長さが長いと、かかる入口部を当該人工弁により、詳しくは弁形成部の筒状部により塞いでしまうおそれがある。これに対して、人工弁の軸線方向長さをある程度確保しないと、人工弁を安定した状態で留置させることが困難になってしまう。そこで本発明では、これらの点に鑑みて、ステントの各柱部に筒状部よりも軸線方向に延出した延出部を設けている。この場合、筒状部の軸線方向長さを短く抑えながら、ステントの柱部の軸線方向長さを確保することができるため、左冠動脈や右冠動脈の入口部を塞いでしまう事態を回避しながら、人工弁を安定した状態で留置させることが可能となる。
By the way, the entrance of the left coronary artery and the right coronary artery is present around the aortic valve of the heart in the body. Therefore, when an artificial valve with a stent is to be placed in the body as a replacement valve for an aortic valve, if the axial length of the artificial valve is long, the inlet portion is formed by the artificial valve, more specifically by the tubular portion of the valve forming portion. There is a risk of blocking. In contrast, if the axial length of the artificial valve is not secured to some extent, it becomes difficult to place the artificial valve in a stable state. Therefore, in the present invention, in view of these points, each column portion of the stent is provided with an extending portion extending in the axial direction from the tubular portion. In this case, the axial length of the stent column can be secured while keeping the axial length of the cylindrical portion short, so that the situation where the left coronary artery or the right coronary artery is blocked by the entrance is avoided. It becomes possible to place the artificial valve in a stable state.
〔第1の実施形態〕
以下、本発明を具体化した一実施の形態について図面に基づいて説明する。本実施形態では、ステント付き人工弁を疾患のある心臓の大動脈弁に置き換えられる置換弁として具体化している。図1は本実施形態におけるステント付き人工弁を示す斜視図であり、(a)が当該人工弁の閉弁状態を示しており、(b)が開弁状態を示している。また、図2はステント付き人工弁を軸線方向から見た正面図である。図3はステント付き人工弁を構成するステントの斜視図であり、図4はそのステントを展開した状態で示す展開図である。 [First Embodiment]
Hereinafter, an embodiment of the present invention will be described with reference to the drawings. In this embodiment, the stented prosthetic valve is embodied as a replacement valve that can be replaced with a diseased heart aortic valve. FIG. 1 is a perspective view showing a prosthetic valve with a stent according to the present embodiment, in which (a) shows a closed state of the artificial valve, and (b) shows a valve open state. Moreover, FIG. 2 is the front view which looked at the artificial valve with a stent from the axial direction. FIG. 3 is a perspective view of a stent constituting the prosthetic valve with a stent, and FIG. 4 is a developed view showing the expanded state of the stent.
以下、本発明を具体化した一実施の形態について図面に基づいて説明する。本実施形態では、ステント付き人工弁を疾患のある心臓の大動脈弁に置き換えられる置換弁として具体化している。図1は本実施形態におけるステント付き人工弁を示す斜視図であり、(a)が当該人工弁の閉弁状態を示しており、(b)が開弁状態を示している。また、図2はステント付き人工弁を軸線方向から見た正面図である。図3はステント付き人工弁を構成するステントの斜視図であり、図4はそのステントを展開した状態で示す展開図である。 [First Embodiment]
Hereinafter, an embodiment of the present invention will be described with reference to the drawings. In this embodiment, the stented prosthetic valve is embodied as a replacement valve that can be replaced with a diseased heart aortic valve. FIG. 1 is a perspective view showing a prosthetic valve with a stent according to the present embodiment, in which (a) shows a closed state of the artificial valve, and (b) shows a valve open state. Moreover, FIG. 2 is the front view which looked at the artificial valve with a stent from the axial direction. FIG. 3 is a perspective view of a stent constituting the prosthetic valve with a stent, and FIG. 4 is a developed view showing the expanded state of the stent.
図1及び図2に示すように、ステント付き人工弁10(以下、単に人工弁10という)は、ステント11と、そのステント11によって保持される弁形成部12とを備える。ステント11は、図3及び図4に示すように、複数の線状要素によって全体として管状(円管状)に形成されている。ステント11は、塑性変形可能な金属材料により形成されており、具体的にはコバルトクロム合金により形成されている。ステント11は、塑性変形を行うことで収縮状態とそれよりも外径が大きくなる拡張状態との間で遷移可能となっており、図3及び図4ではいずれもステント11の拡張状態を示している。また、ステント11の形成材料であるコバルトクロム合金は造影機能(X線不透過性)を有する材料であり、X線投影下においてステント11を視認することが可能となっている。
As shown in FIGS. 1 and 2, the stented artificial valve 10 (hereinafter simply referred to as the artificial valve 10) includes a stent 11 and a valve forming portion 12 held by the stent 11. As shown in FIGS. 3 and 4, the stent 11 is formed into a tubular shape (circular tubular shape) as a whole by a plurality of linear elements. The stent 11 is formed of a metal material that can be plastically deformed, and is specifically formed of a cobalt chromium alloy. The stent 11 can transition between a contracted state and an expanded state in which the outer diameter is larger than that by performing plastic deformation. FIGS. 3 and 4 both show the expanded state of the stent 11. Yes. Moreover, the cobalt chromium alloy which is a forming material of the stent 11 is a material having a contrast function (X-ray opacity), and the stent 11 can be visually recognized under X-ray projection.
なお、ステント11は、例えばコバルトクロム合金よりなる筒状体(チューブ)をレーザカットすることにより製造される。また、ステント11は、必ずしもコバルトクロム合金により形成される必要はなく、ステンレスやチタン等他の金属材料により形成されてもよい。
In addition, the stent 11 is manufactured by laser-cutting a cylindrical body (tube) made of, for example, a cobalt chromium alloy. Moreover, the stent 11 does not necessarily need to be formed with a cobalt chromium alloy, and may be formed with other metal materials, such as stainless steel and titanium.
ステント11は、軸線方向に延びるとともに周方向に所定の間隔(詳しくは等間隔)で設けられた複数(具体的には3つ)の柱部14と、周方向に隣り合う柱部14同士を互いに連結する複数の連結部15とを備える。柱部14は、軸線方向に延びるとともに周方向に並んで設けられた一対の柱材17と、それら各柱材17同士を繋ぐ複数の繋ぎ材18とを有している。柱材17と繋ぎ材18とはいずれも線状要素によって形成されている。
The stent 11 includes a plurality of (specifically three) column portions 14 extending in the axial direction and provided at predetermined intervals (specifically, equal intervals) in the circumferential direction, and column portions 14 adjacent to each other in the circumferential direction. And a plurality of connecting portions 15 connected to each other. The column portion 14 includes a pair of column members 17 provided in the axial direction and extending in the axial direction, and a plurality of connecting members 18 that connect the column members 17 to each other. Both the column member 17 and the connecting member 18 are formed of linear elements.
連結部15は、線状要素によって周方向に延びる波線状に形成されており、軸線方向の両端部において交互に折り返された形状を有している。連結部15は、隣り合う柱部14の間に配設され、周方向の両端部がそれら各柱部14にそれぞれ連結されている。具体的には、連結部15は、その両端部が隣り合う柱部14において周方向に互いに近い側の各柱材17にそれぞれ連結されている。
The connecting portion 15 is formed in a wavy shape extending in the circumferential direction by a linear element, and has a shape that is alternately folded at both ends in the axial direction. The connection part 15 is arrange | positioned between the adjacent pillar parts 14, and the both ends of the circumferential direction are each connected with these each pillar part 14. As shown in FIG. Specifically, the connecting portion 15 is connected to each column member 17 on the side close to each other in the circumferential direction in the column portions 14 whose both ends are adjacent to each other.
連結部15は、隣り合う柱部14間ごとにそれぞれ軸線方向に所定間隔(詳しくは等間隔)で複数ずつ配置され、本実施形態では3つずつ配置されている。また、隣り合う柱部14間における各連結部15の軸線方向の位置(関係)は、各柱部14間でそれぞれ同じとされている。したがって、周方向で見た場合、複数の連結部15が同方向に沿って並んで配置されており、そしてその周方向に並んだ複数の連結部15の列が3列に亘って設けられている。なお、連結部15の列の数は必ずしも3列に限ることなく、1列や2列又は4列以上であってもよい。
A plurality of connecting portions 15 are arranged at predetermined intervals (specifically, equally spaced) in the axial direction for each of the adjacent column portions 14, and three connecting portions 15 are arranged in this embodiment. Further, the positions (relationships) of the connecting portions 15 in the axial direction between the adjacent column portions 14 are the same between the column portions 14. Accordingly, when viewed in the circumferential direction, the plurality of connecting portions 15 are arranged along the same direction, and the rows of the plurality of connecting portions 15 arranged in the circumferential direction are provided over three rows. Yes. Note that the number of columns of the connecting portion 15 is not necessarily limited to three, and may be one, two, or four or more.
各連結部15はいずれも同じ構成を有しており、互いに同じ向きで配置されている。連結部15は、その周方向の両端部がそれぞれ当該連結部15の波線の頂部15aに相当しており、詳しくは軸線方向における同じ側の頂部15aに相当している。この場合、連結部15における周方向の両端部がそれぞれ軸線方向において同位置に位置しており、したがって連結部15両端における各柱部14との連結箇所がそれぞれ軸線方向にて同位置に位置している。
All the connecting portions 15 have the same configuration and are arranged in the same direction. Both end portions of the connecting portion 15 in the circumferential direction correspond to the wavy line apex portion 15a of the connecting portion 15, and specifically correspond to the apex portion 15a on the same side in the axial direction. In this case, both end portions in the circumferential direction of the connecting portion 15 are positioned at the same position in the axial direction, and accordingly, the connecting portions with the column portions 14 at both ends of the connecting portion 15 are positioned at the same position in the axial direction. ing.
柱部14において一対の柱材17にはそれぞれ当該柱部14を挟んで周方向に隣り合う各連結部15が連結されている。この場合、一対の柱材17のうち一方の柱材17における連結部15との連結箇所と、他方の柱材17における連結部15との連結箇所とが軸線方向において同位置とされている。
In the column portion 14, each of the connection portions 15 adjacent to each other in the circumferential direction is connected to the pair of column members 17 with the column portion 14 interposed therebetween. In this case, the connection location with the connection part 15 in one pillar material 17 and the connection location with the connection part 15 in the other pillar material 17 are set to the same position in the axial direction.
続いて、柱部14について詳しく説明する。
Subsequently, the column portion 14 will be described in detail.
柱部14には、上述したように、一対の柱材17同士を繋ぐ複数の繋ぎ材18が設けられている。これら複数の繋ぎ材18は、一対の柱材17間において軸線方向(換言すると柱材17の長手方向)に並べて設けられている。
As described above, the column portion 14 is provided with a plurality of connecting members 18 that connect the pair of column members 17 to each other. The plurality of connecting members 18 are provided side by side in the axial direction (in other words, the longitudinal direction of the column member 17) between the pair of column members 17.
複数の繋ぎ材18には、軸線方向(換言すると柱材17の長手方向)に対して所定の側に傾斜して延びる第1斜め繋ぎ材18aと、軸線方向に対して第1斜め繋ぎ材18aとは逆側に傾斜して延びる第2斜め繋ぎ材18bと、軸線方向に対して直交する方向に延びる直交繋ぎ材18cとが含まれている。これら各繋ぎ材18a~18cはいずれも略四角形状の断面を有する線状要素によって形成されている。
The plurality of connecting members 18 include a first oblique connecting member 18a extending obliquely toward a predetermined side with respect to the axial direction (in other words, the longitudinal direction of the column member 17), and a first oblique connecting member 18a with respect to the axial direction. The 2nd diagonal joining material 18b which inclines in the opposite side and is extended, and the orthogonal joining material 18c extended in the direction orthogonal to an axial direction are contained. Each of the connecting members 18a to 18c is formed of a linear element having a substantially square cross section.
第1斜め繋ぎ材18aは、各柱材17間において一方の柱材17から他方の柱材17に向かうにつれて軸線方向の一方側に傾斜して延びており、第2斜め繋ぎ材18bは、一方の柱材17から他方の柱材17に向かうにつれて軸線方向の他方側に傾斜して延びている。第1斜め繋ぎ材18aと第2斜め繋ぎ材18bとはそれぞれ複数ずつ設けられている。第1斜め繋ぎ材18aと第2斜め繋ぎ材18bとは軸線方向に交互に並ぶように配置されており、隣り合う第1斜め繋ぎ材18aと第2斜め繋ぎ材18bとが互いの端部同士にて連結されている。これにより、複数の第1斜め繋ぎ材18aと複数の第2斜め繋ぎ材18bとが軸線方向にジグザグ状に連続している。なお、この場合第1斜め繋ぎ材18aが第1繋ぎ材に相当し、第2斜め繋ぎ材18bが第2繋ぎ材に相当する。また、各斜め繋ぎ材18a,18bは、一対の柱材17間において当該柱材17の長手方向全域に亘って配置されている。
The first diagonal connecting member 18a extends incline toward one side in the axial direction from one column member 17 to the other column member 17 between the respective column members 17, and the second diagonal connecting member 18b As it goes from the column member 17 to the other column member 17, the column member 17 is inclined to the other side in the axial direction. A plurality of first oblique connecting members 18a and a plurality of second oblique connecting members 18b are provided. The first diagonal connecting members 18a and the second diagonal connecting members 18b are arranged so as to be alternately arranged in the axial direction, and the adjacent first diagonal connecting members 18a and the second diagonal connecting members 18b are mutually end portions. It is connected with. As a result, the plurality of first oblique connecting members 18a and the plurality of second oblique connecting members 18b are continuous in a zigzag shape in the axial direction. In this case, the first diagonal connecting material 18a corresponds to the first connecting material, and the second diagonal connecting material 18b corresponds to the second connecting material. In addition, the diagonal connecting members 18 a and 18 b are disposed across the entire longitudinal direction of the column member 17 between the pair of column members 17.
隣り合う第1斜め繋ぎ材18a及び第2斜め繋ぎ材18bは、それら斜め繋ぎ材18a,18b同士が連結する連結端部28においてそれぞれ柱材17と連結されている。これにより、柱部14では、第1斜め繋ぎ材18aと第2斜め繋ぎ材18bと柱材17とからなるトラス(三角)が軸線方向に連続して形成されている。
The adjacent first diagonal connecting material 18a and second diagonal connecting material 18b are connected to the column member 17 at a connecting end portion 28 where the diagonal connecting materials 18a and 18b are connected to each other. Thereby, in the pillar part 14, the truss (triangle) which consists of the 1st diagonal connection material 18a, the 2nd diagonal connection material 18b, and the pillar material 17 is formed continuously in the axial direction.
第1斜め繋ぎ材18aは、軸線方向に対する傾斜角度α(詳しくは鋭角側の傾斜角度α)が30°~60°の範囲に設定されており、具体的には45°に設定されている。一方、第2斜め繋ぎ材18bも、第1斜め繋ぎ材18aと同様、軸線方向に対する傾斜角度β(詳しくは鋭角側の傾斜角度β)が30°~60°の範囲に設定されており、具体的には45°に設定されている。したがって、本実施形態では、第1斜め繋ぎ材18aの傾斜角度αと第2斜め繋ぎ材18bの傾斜角度βとがそれぞれ同じ角度に設定されている。
The inclination angle α (specifically, the inclination angle α on the acute angle side) with respect to the axial direction of the first oblique connecting member 18a is set in a range of 30 ° to 60 °, and specifically, set to 45 °. On the other hand, the second oblique connecting member 18b also has an inclination angle β (specifically, an acute angle side inclination angle β) in the range of 30 ° to 60 ° with respect to the axial direction, like the first oblique connecting member 18a. Specifically, it is set to 45 °. Therefore, in the present embodiment, the inclination angle α of the first oblique connecting member 18a and the inclination angle β of the second oblique connecting member 18b are respectively set to the same angle.
但し、第1斜め繋ぎ材18aの傾斜角度αと第2斜め繋ぎ材18bの傾斜角度βとは必ずしも同じ角度とする必要はなく、異なる角度としてもよい。また、第1斜め繋ぎ材18aの傾斜角度αを各第1斜め繋ぎ材18aごとに異ならせてもよく、また第2斜め繋ぎ材18bの傾斜角度βを各第2斜め繋ぎ材18bごとに異ならせてもよい。
However, the inclination angle α of the first oblique connecting member 18a and the inclination angle β of the second oblique connecting member 18b are not necessarily the same angle, and may be different angles. In addition, the inclination angle α of the first diagonal connecting member 18a may be different for each first diagonal connecting member 18a, and the inclination angle β of the second diagonal connecting member 18b may be different for each second diagonal connecting member 18b. It may be allowed.
また、第1斜め繋ぎ材18aと第2斜め繋ぎ材18bとはそれぞれ同じ太さの線状要素によって形成されている。したがって、各斜め繋ぎ材18a,18bの線幅はいずれも同じ線幅D1となっており、本実施形態ではその線幅D1が0.254mmに設定されている。なお、各斜め繋ぎ材18a,18bは必ずしも同じ太さの線状要素により形成する必要はなく、互いに異なる太さの線状要素により形成してもよい。
Further, the first diagonal connecting material 18a and the second diagonal connecting material 18b are each formed by linear elements having the same thickness. Accordingly, the line widths of the diagonal connecting members 18a and 18b are all the same line width D1, and in the present embodiment, the line width D1 is set to 0.254 mm. Note that the diagonal connecting members 18a and 18b are not necessarily formed by linear elements having the same thickness, and may be formed by linear elements having different thicknesses.
直交繋ぎ材18cは、一対の柱材17間において軸線方向に所定間隔で複数設けられている。直交繋ぎ材18cは、柱部14を挟んで周方向に隣り合う各連結部15の間ごとにそれぞれ配置されている。直交繋ぎ材18cは、柱部14の各柱材17のうち一方の柱材17における連結部15との連結箇所と、他方の柱材17における連結部15との連結箇所とを互いに繋ぐように設けられている。
A plurality of orthogonal connecting members 18c are provided at predetermined intervals in the axial direction between the pair of column members 17. The orthogonal connecting members 18c are respectively arranged between the connecting portions 15 adjacent in the circumferential direction with the column portion 14 interposed therebetween. The orthogonal connecting member 18 c connects the connecting portion of the one pillar member 17 with the connecting portion 15 and the connecting portion of the other pillar member 17 with the connecting portion 15 among the pillar members 17 of the pillar portion 14. Is provided.
直交繋ぎ材18cは、隣り合う第1斜め繋ぎ材18aと第2斜め繋ぎ材18bとの境界部に配置されており、その一端部がそれら斜め繋ぎ材18a,18b同士が連結し合う連結端部28に連結されている。したがって、当該連結端部28では、第1斜め繋ぎ材18a、第2斜め繋ぎ材18b、直交繋ぎ材18c及び柱材17の4者が連結されている。
The orthogonal connecting member 18c is disposed at a boundary portion between the adjacent first oblique connecting member 18a and the second oblique connecting member 18b, and one end portion of the orthogonal connecting member 18c connects the oblique connecting members 18a and 18b. 28. Therefore, at the connection end portion 28, the four members of the first diagonal connecting member 18a, the second diagonal connecting member 18b, the orthogonal connecting member 18c, and the column member 17 are connected.
直交繋ぎ材18cは、斜め繋ぎ材18a,18bよりも太い線状要素により形成されている。したがって、直交繋ぎ材18cの線幅D2は斜め繋ぎ材18a,18bの線幅D1よりも大きくなっており、本実施形態では0.439mmに設定されている。但し、直交繋ぎ材18cは必ずしも斜め繋ぎ材18a,18bよりも太い線状要素により形成する必要はなく、斜め繋ぎ材18a,18bより細い線状要素により形成してもよいし、斜め繋ぎ材18a,18bと同じ太さの線状要素により形成してもよい。
The orthogonal connecting member 18c is formed of a linear element that is thicker than the oblique connecting members 18a and 18b. Therefore, the line width D2 of the orthogonal connecting member 18c is larger than the line width D1 of the oblique connecting members 18a and 18b, and is set to 0.439 mm in this embodiment. However, the orthogonal connecting material 18c is not necessarily formed by a linear element thicker than the oblique connecting materials 18a and 18b, and may be formed by a linear element thinner than the oblique connecting materials 18a and 18b, or the oblique connecting material 18a. , 18b may be formed by linear elements having the same thickness.
一対の柱材17間において隣り合う繋ぎ材18a~18c同士の間には所定の隙間23が形成されている。この隙間23は、後述するように弁形成部12の一部が入り込む部分となっている。
A predetermined gap 23 is formed between the adjacent connecting members 18a to 18c between the pair of column members 17. The gap 23 is a portion into which a part of the valve forming portion 12 enters as will be described later.
柱部14には、上記各繋ぎ材18a~18cの他に、一対の端部繋ぎ材18d,18eが繋ぎ材18として設けられている。端部繋ぎ材18dは各柱材17における軸線方向の一端部同士を連結しており、端部繋ぎ材18eは各柱材17における軸線方向の他端部同士を連結している。これら各端部繋ぎ材18d,18eは、軸線方向において互いに逆側に凸となる円弧状をなしている。
In addition to the connecting members 18a to 18c, the column portion 14 is provided with a pair of end connecting members 18d and 18e as the connecting members 18. The end connecting member 18d connects one end portions of the column members 17 in the axial direction, and the end connecting member 18e connects the other end portions of the column members 17 in the axial direction. Each of the end connecting members 18d and 18e has an arc shape that is convex on the opposite side in the axial direction.
各柱部14はそれぞれ、複数の連結部15よりも軸線方向の一方側に延出する延出部19を有している。延出部19の延出長さは、軸線方向に隣り合う連結部15間の間隔(ピッチ)と同じか又はそれよりも大きい寸法に設定されている。一方、各柱部14はそれぞれ、複数の連結部15よりも軸線方向における他方側には延出していない。具体的には、各柱部14はそれぞれ、軸線方向における他方側の端部が、複数の連結部15における当該他方側の端部(より詳しくは他方側の連結部15における当該他方側の頂部)と同位置に設定されている。
Each pillar part 14 has the extension part 19 extended to the one side of an axial direction rather than the some connection part 15, respectively. The extension length of the extension part 19 is set to be the same as or larger than the interval (pitch) between the connecting parts 15 adjacent in the axial direction. On the other hand, each column portion 14 does not extend to the other side in the axial direction from the plurality of connecting portions 15. Specifically, each column portion 14 has an end portion on the other side in the axial direction, the end portion on the other side in the plurality of connecting portions 15 (more specifically, the top portion on the other side in the connecting portion 15 on the other side). ).
以上が、ステント11についての説明である。
The above is an explanation of the stent 11.
次に、弁形成部12について図1及び図2に基づいて説明する。
Next, the valve forming unit 12 will be described with reference to FIGS.
弁形成部12は、動物の組織体により形成されている。本実施形態では、弁形成部12が人体の組織体により形成されており、具体的には患者自ら(自己)の組織体(すなわち自家組織)により形成されている。したがって、弁形成部12は、生体適合性及び血液適合性に優れたものとなっている。弁形成部12は、図1及び図2に示すように、ステント11全体を覆う(埋設させる)ように形成されており、これによりステント11と一体化されている。
The valve forming part 12 is formed of an animal tissue. In this embodiment, the valve forming part 12 is formed of a human body, and specifically, is formed of a patient's own (self) tissue (that is, a self tissue). Therefore, the valve forming part 12 has excellent biocompatibility and blood compatibility. As shown in FIGS. 1 and 2, the valve forming portion 12 is formed so as to cover (embed) the entire stent 11, and thereby integrated with the stent 11.
弁形成部12は、円筒状の筒状部21と、筒状部21の内周側に設けられる複数(本実施形態では3つ)の弁膜22とを備える。これら筒状部21と各弁膜22とは上記組織体によって一体的に形成されている。筒状部21は、ステント11と同軸(中心位置が同一)に配置され、軸線方向において複数の連結部15における一方側の端部から他方側の端部までの範囲(換言すると、柱部14における延出部19を除いた部分の全域)に亘り形成されている。筒状部21の内部には、各連結部15と各柱部14とがそれぞれ埋設され、それによって筒状部21が各連結部15及び各柱部14と一体化されている。
The valve forming portion 12 includes a cylindrical tubular portion 21 and a plurality (three in the present embodiment) of valve membranes 22 provided on the inner peripheral side of the tubular portion 21. The cylindrical portion 21 and each valve membrane 22 are integrally formed by the tissue body. The cylindrical portion 21 is disposed coaxially with the stent 11 (the center position is the same), and ranges from one end portion to the other end portion (in other words, the column portion 14) in the plurality of connecting portions 15 in the axial direction. In the entire region except for the extending portion 19). Each connecting portion 15 and each column portion 14 are embedded in the inside of the cylindrical portion 21, whereby the cylindrical portion 21 is integrated with each connecting portion 15 and each column portion 14.
特に、柱部14では、筒状部21(弁形成部12)の組織体の一部が当該柱部14の各隙間23に入り込んでおり、その隙間23に入り込んだ組織体が、当該柱部14をその(表裏)両側からそれぞれ覆う組織体同士を互いに繋いでいる。そのため、筒状部21は、各柱部14に対して比較的強固に一体化された状態となっている。また、柱部14において延出部19は筒状部21よりも軸線方向の一方側に延出しており、筒状部21には埋設されていない。
In particular, in the column portion 14, a part of the tissue body of the cylindrical portion 21 (valve forming portion 12) enters each gap 23 of the column portion 14, and the tissue body that enters the gap 23 corresponds to the column portion. The tissues covering 14 from both sides (front and back) are connected to each other. Therefore, the cylindrical portion 21 is in a state of being relatively firmly integrated with each column portion 14. Further, in the column part 14, the extending part 19 extends to one side in the axial direction from the cylindrical part 21, and is not embedded in the cylindrical part 21.
弁膜22は、心臓の拍動に合わせて開弁及び閉弁動作する可動部であり、心臓が収縮して心臓から血液が送り出される際にはその血流により押されて開弁状態(図1(b)参照)となり、心臓が弛緩して心臓からの血液の送り出しが終わると閉弁状態(図1(a)参照)となる。弁膜22は、軸線方向から見て扇状をなしており、筒状部21の軸線回りに複数並べて配置されている(図2参照)。
The valve membrane 22 is a movable part that opens and closes in accordance with the pulsation of the heart. When the heart contracts and blood is pumped from the heart, the valve membrane 22 is pushed by the blood flow to open the valve (FIG. 1). (See (b)). When the heart relaxes and blood delivery from the heart ends, the valve is closed (see FIG. 1 (a)). The valve membrane 22 has a fan shape when viewed from the axial direction, and a plurality of the valve membranes 22 are arranged around the axial line of the cylindrical portion 21 (see FIG. 2).
各弁膜22はそれぞれ筒状部21から内周側に向けて扇状に延びており、隣り合う弁膜22との境界部においてさらに軸線方向の一方側(延出部19の延出側)に向けて延びている。弁膜22において当該一方側に延びている部分は開閉部22aとなっている。隣り合う弁膜22同士の境界部では、それら各弁膜22の開閉部22a同士が互いに向き合って配置されており、それら開閉部22a同士が互いに接離することで弁膜22が閉弁状態と開弁状態とに開閉動作するようになっている。また、開閉部22aは、軸線方向において筒状部21よりも前記一方側に延出しており、より詳しくはその延出長さが柱部14における延出部19の延出長さと略同じとなっている。
Each valve membrane 22 extends in a fan shape from the tubular portion 21 toward the inner peripheral side, and further toward one side in the axial direction (extending side of the extending portion 19) at the boundary portion with the adjacent valve membrane 22. It extends. A portion extending to the one side in the valve membrane 22 is an opening / closing portion 22a. At the boundary between adjacent valve membranes 22, the opening / closing portions 22 a of the respective valve membranes 22 are arranged to face each other, and the opening / closing portions 22 a come in contact with each other so that the valve membrane 22 is in a closed state and an opened state. It is designed to open and close. The opening / closing part 22a extends in the axial direction to the one side with respect to the tubular part 21, and more specifically, the extension length is substantially the same as the extension length of the extension part 19 in the column part 14. It has become.
隣り合う弁膜22同士の各境界部は、それぞれ周方向においてステント11の各柱部14と同位置に位置している。それら隣り合う弁膜22の各開閉部22aは、その径方向外側の端部にて柱部14の延出部19と接合されている。詳しくは、各開閉部22aは当該端部において延出部19を覆うように形成されており、それによって延出部19(ひいては柱部14)と一体化されている。この場合、各弁膜22は隣り合う柱部14(延出部19)間では径方向内側に凹んだ形状をなしている。なお、延出部19においてもその隙間23に組織体が入り込み、その入り込んだ組織体により延出部19を挟んだ両側部分の組織体が互いに繋がれている。
Each boundary between adjacent valve membranes 22 is located at the same position as each column 14 of the stent 11 in the circumferential direction. Each of the opening / closing portions 22a of the adjacent valve membranes 22 is joined to the extending portion 19 of the column portion 14 at its radially outer end. Specifically, each opening / closing portion 22a is formed so as to cover the extending portion 19 at the end portion, and thereby integrated with the extending portion 19 (and thus the column portion 14). In this case, each valve membrane 22 has a shape recessed inward in the radial direction between adjacent column portions 14 (extension portions 19). Note that the tissue body also enters the gap 23 in the extended portion 19, and the tissue bodies on both sides of the extended portion 19 are connected to each other by the inserted tissue body.
なお、本実施形態の弁形成部12は、ステント11に対して一切縫合されることなくステント11と一体化されている。また、弁形成部12は人工物を一切含まず、人体の組織体のみによって形成されたものとなっている。
Note that the valve forming portion 12 of the present embodiment is integrated with the stent 11 without being sutured to the stent 11 at all. Further, the valve forming portion 12 does not include any artificial object, and is formed only by a human tissue.
次に、人工弁10を製造する際の製造手順について簡単に説明する。
Next, a manufacturing procedure for manufacturing the artificial valve 10 will be briefly described.
まず、弁形成部12の形状に合わせて形成された鋳型(型部材)に拡張状態のステント11を外挿し組み付ける。そして、この組み付け状態でステント11を鋳型とともに患者(自己)の体内に埋入する。この際、ステント11は、例えば腹腔内や四肢部等ある程度の大きさ(容積)を有する部位に埋入される。なお、ステント11は、皮下に埋入してもよい。
First, the expanded stent 11 is extrapolated and assembled to a mold (mold member) formed in accordance with the shape of the valve forming portion 12. Then, in this assembled state, the stent 11 is implanted into the patient's (self) body together with the mold. At this time, the stent 11 is embedded in a site having a certain size (volume) such as an abdominal cavity or an extremity. The stent 11 may be implanted subcutaneously.
ステント11を体内に埋入すると、ステント11周りの組織体が当該ステント11を覆うように鋳型表面上で成長を始める。組織体の成長は時間の経過とともに進行し、やがてステント11全体が組織体により覆われた状態となる。その後、ステント11を鋳型とともに体内から取り出す。
When the stent 11 is embedded in the body, the tissue around the stent 11 starts to grow on the mold surface so as to cover the stent 11. The growth of the tissue progresses with time, and eventually the entire stent 11 is covered with the tissue. Thereafter, the stent 11 is taken out from the body together with the mold.
ステント11の取り出し後、ステント11を覆った状態で形成された組織体に切り込みを入れたり、組織体のうち不要な部分をカットしたりする等して、弁形成部12を形成する。その後、ステント11から鋳型を引き抜く。これにより、人工弁10の製造が完了する。
After the stent 11 is taken out, the valve forming portion 12 is formed by cutting the tissue body formed in a state of covering the stent 11 or cutting unnecessary portions of the tissue body. Thereafter, the mold is pulled out from the stent 11. Thereby, manufacture of the artificial valve 10 is completed.
次に、人工弁10を疾患のある大動脈弁の置換弁として体内に留置する場合の様子について図5を用いながら説明する。図5は、人工弁10が大動脈弁の置換弁として体内に留置された様子を説明するための説明図であり、(a)が当該様子を正面から見た図、(b)が上方から見た図となっている。
Next, how the artificial valve 10 is placed in the body as a replacement valve for a diseased aortic valve will be described with reference to FIG. FIGS. 5A and 5B are explanatory views for explaining a state in which the artificial valve 10 is placed in the body as a replacement valve for an aortic valve. FIG. 5A is a front view of the artificial valve 10 and FIG. It is a figure.
本実施形態では、上述したように、人工弁10を大動脈弁がある所定の留置部位までバルーンカテーテルを用いて搬送することとしている。図示は省略するが、バルーンカテーテルは、周知の通り、その先端側に膨張及び収縮可能なバルーンを有している。人工弁10は、収縮状態にあるバルーンの外周面上に搭載された状態で留置部位へと搬送される。具体的には、人工弁10は、ステント11がバルーン上にクリンプされて収縮状態とされることでバルーン上に搭載される。この搭載状態では、弁形成部12(筒状部21)の内側にバルーンが挿通され弁膜22が開いた状態とされる。
In this embodiment, as described above, the artificial valve 10 is transported to a predetermined indwelling site where the aortic valve is located using a balloon catheter. Although not shown, the balloon catheter has a balloon that can be inflated and deflated on the distal end side, as is well known. The artificial valve 10 is transported to the indwelling site while being mounted on the outer peripheral surface of the balloon in a deflated state. Specifically, the artificial valve 10 is mounted on the balloon by the stent 11 being crimped onto the balloon to be in a contracted state. In this mounted state, a balloon is inserted inside the valve forming portion 12 (tubular portion 21) and the valve membrane 22 is opened.
人工弁10をバルーンカテーテルを用いて大動脈弁のある所定の留置部位へ搬送するためのアプローチとしては、種々のアプローチが考えられる。例えば、心臓の左心室下部の壁部に孔部を設け、その孔部を通じて人工弁10を左心室を経由させて留置部位へ導入するアプローチが考えられる。この場合、予めその孔部を通じてガイドワイヤGを上行大動脈BV1(図5(a)参照)まで導入しておき、そのガイドワイヤGに沿って人工弁10が搭載されたバルーンカテーテルを導入する。そして、バルーン上の人工弁10を上行大動脈BV1の起始部に位置するバルサルバ洞BV2(図5(a)参照)における留置部位まで搬送する。
As an approach for delivering the artificial valve 10 to a predetermined indwelling site having an aortic valve using a balloon catheter, various approaches can be considered. For example, an approach is conceivable in which a hole is provided in the lower wall of the left ventricle of the heart and the artificial valve 10 is introduced into the indwelling site through the hole through the left ventricle. In this case, a guide wire G is introduced to the ascending aorta BV1 (see FIG. 5A) in advance through the hole, and a balloon catheter on which the artificial valve 10 is mounted is introduced along the guide wire G. And the artificial valve 10 on a balloon is conveyed to the indwelling site | part in Valsalva sinus BV2 (refer Fig.5 (a)) located in the origin part of the ascending aorta BV1.
搬送後、バルーン内に圧縮流体を注入することでバルーンを膨張させ、ステント11(ひいては人工弁10)を収縮状態から拡張状態へと変形させる。これにより、図5(a)に示すように、人工弁10がステント11の拡張状態で所定の留置部位に留置される。人工弁10を留置後、バルーン内に注入された圧縮流体を抜き取ることでバルーンを収縮させ、バルーンカテーテルを体内から抜き取る。これにより、人工弁10の留置作業が完了する。
After transportation, the balloon is inflated by injecting a compressed fluid into the balloon, and the stent 11 (and thus the artificial valve 10) is deformed from the contracted state to the expanded state. Thereby, as shown in FIG. 5A, the artificial valve 10 is indwelled at a predetermined indwelling site in the expanded state of the stent 11. After the artificial valve 10 is placed, the balloon is deflated by extracting the compressed fluid injected into the balloon, and the balloon catheter is extracted from the body. Thereby, the indwelling work of the artificial valve 10 is completed.
続いて、体内における人工弁10の留置状態について説明する。
Subsequently, the indwelling state of the artificial valve 10 in the body will be described.
図5(a)に示すように、人工弁10は、バルサルバ洞V2において疾患のある大動脈弁BV3が形成されている部位に留置されている。人工弁10は、大動脈弁BV3の内側部分に配置され、その配置によって大動脈弁BV3が上側に捲れ上がった状態となっている。上行大動脈BV1において、大動脈弁BV3よりも上側(血流方向の下流側)には左冠動脈BV4の入口部と右冠動脈BV5の入口部とが設けられている。左冠動脈BV4の入口部と右冠動脈BV5の入口部とは、図5(b)に示すように、バルサルバ洞V2を挟んで互いに向き合うように位置している。
As shown in FIG. 5 (a), the prosthetic valve 10 is indwelled at a site where a diseased aortic valve BV3 is formed in Valsalva sinus V2. The prosthetic valve 10 is disposed in the inner part of the aortic valve BV3, and the aortic valve BV3 is swollen upward by the arrangement. In the ascending aorta BV1, an inlet of the left coronary artery BV4 and an inlet of the right coronary artery BV5 are provided above the aortic valve BV3 (downstream in the blood flow direction). As shown in FIG. 5B, the entrance portion of the left coronary artery BV4 and the entrance portion of the right coronary artery BV5 are positioned so as to face each other across the Valsalva sinus V2.
人工弁10は、ステント11の各柱部14の延出部19を上側(換言すると冠動脈BV4,BV5の入口部側)に向けた状態で留置されている。この場合、人工弁10は、筒状部21が各冠動脈BV4,BV5の入口部よりも下方に位置するように配置されている。これにより、筒状部21により各冠動脈BV4,BV5の入口部が塞がれてしまうことが回避されている。
The artificial valve 10 is indwelled in a state in which the extending portions 19 of the column portions 14 of the stent 11 face upward (in other words, the inlet portions of the coronary arteries BV4 and BV5). In this case, the artificial valve 10 is disposed such that the cylindrical portion 21 is located below the inlet portions of the coronary arteries BV4 and BV5. Thereby, it is avoided that the inlet part of each coronary artery BV4, BV5 will be obstruct | occluded by the cylindrical part 21. FIG.
また、人工弁10は、各柱部14がそれぞれ周方向において各冠動脈BV4,BV5の入口部と重複しないように配置されている(図5(b)参照)。これにより、各冠動脈BV4,BV5の入口部が柱部14の延出部19によって塞がれてしまうことが回避されている。したがって、かかる人工弁10の留置状態では、バルサルバ洞V2から各冠動脈BV4,BV5への血液の流れ込みが当該人工弁10により阻害されてしまうことがないようになっている。
Further, the artificial valve 10 is arranged such that each column portion 14 does not overlap with the inlet portions of the coronary arteries BV4 and BV5 in the circumferential direction (see FIG. 5B). Thereby, it is avoided that the entrance part of each coronary artery BV4, BV5 is obstruct | occluded by the extension part 19 of the pillar part 14. FIG. Therefore, in the indwelling state of the artificial valve 10, the blood flow from the Valsalva sinus V2 into the coronary arteries BV4 and BV5 is not inhibited by the artificial valve 10.
なお、人工弁10を、各柱部14が各冠動脈BV4,BV5の入口部と重複しないように留置する際には、X線投影下で各柱部14の位置を確認しながら留置作業を行うこととなる。
In addition, when placing the artificial valve 10 so that each column portion 14 does not overlap with the entrance portion of each coronary artery BV4, BV5, the placement operation is performed while confirming the position of each column portion 14 under X-ray projection. It will be.
また、人工弁10には、柱部14に延出部19が設けられているため、筒状部21の軸線方向長さを短く抑えながら、ステント11(柱部14)の軸線方向長さをある程度確保することが可能となっている。このため、人工弁10の留置に際し冠動脈BV4,BV5の入口部を塞いでしまう事態を回避しながら、人工弁10を安定した状態で留置することが可能となっている。
Moreover, since the extension part 19 is provided in the column part 14 in the artificial valve 10, the axial direction length of the stent 11 (column part 14) can be reduced while keeping the axial direction length of the cylindrical part 21 short. It is possible to secure to some extent. For this reason, the artificial valve 10 can be placed in a stable state while avoiding a situation where the inlet portions of the coronary arteries BV4 and BV5 are blocked when the artificial valve 10 is placed.
以上、詳述した本実施形態の構成によれば、以下の優れた効果が得られる。
As described above, according to the configuration of this embodiment described in detail, the following excellent effects can be obtained.
ステント11の柱部14に、一対の柱材17を繋ぐ繋ぎ材18として、軸線方向に対して傾斜して延びる第1斜め繋ぎ材18aと、軸線方向に対して第1斜め繋ぎ材18aとは逆側に傾斜して延びる第2斜め繋ぎ材18bと、軸線方向に対して直交する方向に延びる直交繋ぎ材18cとを設けた。斜め繋ぎ材18a,18bは、軸線方向への成分を含む所定方向に延びている。そのため、柱部14の各柱材17がそれぞれ各々の柱材17に連結された異なる連結部15によって、軸線方向への位置ずれを生じさせる向きに引っ張られた場合に、その引張力に対して抵抗力を付与することができる。これにより、各柱材17の軸線方向への位置ずれを抑制することができ、その結果柱部14の変形を抑制することができる。そのため、体内において人工弁10を安定した状態で留置することが可能となる。
As the connecting member 18 that connects the pair of column members 17 to the column part 14 of the stent 11, the first oblique connecting member 18 a extending obliquely with respect to the axial direction, and the first oblique connecting member 18 a with respect to the axial direction. A second oblique connecting member 18b extending inclined to the opposite side and an orthogonal connecting member 18c extending in a direction orthogonal to the axial direction were provided. The oblique connecting members 18a and 18b extend in a predetermined direction including a component in the axial direction. Therefore, when each column member 17 of the column portion 14 is pulled in a direction that causes a positional shift in the axial direction by a different connecting portion 15 connected to each column member 17, the tensile force is reduced. Resistance can be imparted. Thereby, position shift to the direction of an axis of each pillar material 17 can be controlled, and as a result, deformation of pillar part 14 can be controlled. Therefore, it becomes possible to place the artificial valve 10 in a stable state in the body.
柱部14の変形を抑制する上では、一対の柱材17間に、繋ぎ材18として斜め繋ぎ材18a,18bを数多く配置することが望ましいが、斜め繋ぎ材18a,18bは、柱材17間にそれ程多く配置することはできない。この点、繋ぎ材18として、斜め繋ぎ材18a,18bに加えて直交繋ぎ材18cを設けたことで、柱材17間に繋ぎ材18を比較的多く配置することができ、柱部14の強度を好適に高めることが可能となる。したがって、柱部14の変形を抑制する効果を高めることが可能となる。
In order to suppress the deformation of the column part 14, it is desirable to arrange a large number of diagonal connecting members 18 a and 18 b as connecting members 18 between the pair of column members 17, but the diagonal connecting members 18 a and 18 b are arranged between the column members 17. It is not possible to place so much in In this regard, by providing the orthogonal connecting material 18c in addition to the oblique connecting materials 18a and 18b as the connecting material 18, a relatively large number of the connecting materials 18 can be arranged between the column materials 17, and the strength of the column portion 14 is increased. Can be suitably increased. Accordingly, it is possible to enhance the effect of suppressing the deformation of the column portion 14.
直交繋ぎ材18cと斜め繋ぎ材18a,18bとのうち、その長さが短い側の直交繋ぎ材18cについて、斜め繋ぎ材18a,18bよりも太い線状要素により形成した。この場合、一対の柱材17間において繋ぎ材18が占める割合が大きくなるのを抑制しながら、つまり繋ぎ材18同士の隙間23が小さくなるのを抑制しながら、柱部14の強度を高めることが可能となる。
Among the orthogonal connecting members 18c and the oblique connecting members 18a and 18b, the orthogonal connecting member 18c having a shorter length was formed by a linear element thicker than the oblique connecting members 18a and 18b. In this case, the strength of the column portion 14 is increased while suppressing the proportion of the connecting material 18 occupying between the pair of column materials 17, that is, while suppressing the gap 23 between the connecting materials 18 from becoming small. Is possible.
柱部14の各柱材17のうち一方の柱材17における連結部15との連結箇所と、他方の柱材17における連結部15との連結箇所とが軸線方向において同位置に設定されている構成において、それら各連結箇所を繋ぐように直交繋ぎ材18cを設けた。この場合、柱部14を挟んで隣り合う連結部15同士を直交繋ぎ材18cを介して繋ぐことができるため、それら連結部15同士の位置ずれを抑制することができる。その結果、各連結部15が連結された柱材17同士の位置ずれ抑制効果を高めることができ、ひいては柱部14の変形を抑制する効果を高めることができる。
Of each column member 17 of the column part 14, the connecting part with the connecting part 15 in one column member 17 and the connecting part with the connecting part 15 in the other column member 17 are set at the same position in the axial direction. In the configuration, an orthogonal connecting member 18c is provided so as to connect these connecting portions. In this case, the connecting portions 15 adjacent to each other with the pillar portion 14 interposed therebetween can be connected via the orthogonal connecting member 18c, so that the positional deviation between the connecting portions 15 can be suppressed. As a result, it is possible to increase the effect of suppressing the displacement between the column members 17 to which the respective connecting portions 15 are connected, and as a result, the effect of suppressing the deformation of the column portions 14 can be increased.
繋ぎ材18として、第1斜め繋ぎ材18aと第2斜め繋ぎ材18bとをそれぞれ複数ずつ設けるとともに、第1斜め繋ぎ材18aと第2斜め繋ぎ材18bとを軸線方向に交互に並べて配置し互いの端部同士で連結することで連続させた。この場合、柱部14に、第1斜め繋ぎ材18aと第2斜め繋ぎ材18bと柱材17とによるトラスを軸線方向に連続して形成することができるため、柱部14を極めて強固にすることができる。これにより、柱部14の変形を顕著に抑制することができ、人工弁10の留置状態を著しく安定なものとすることができる。
A plurality of first oblique joining members 18a and a plurality of second oblique joining members 18b are provided as the joining members 18, and the first oblique joining members 18a and the second oblique joining members 18b are alternately arranged in the axial direction. It was made to connect by connecting the edge parts of. In this case, since the truss by the 1st diagonal connection material 18a, the 2nd diagonal connection material 18b, and the column material 17 can be continuously formed in the axial direction in the column part 14, the column part 14 is made very strong. be able to. Thereby, a deformation | transformation of the pillar part 14 can be suppressed notably and the indwelling state of the artificial valve 10 can be made extremely stable.
斜め繋ぎ材18a,18bを、他の繋ぎ材18と互いに交差しないように配置したため、各柱材17間においてそれら両者間に形成される隙間23が著しく小さくなってしまうのを回避することができる。この場合、隙間23を利用して柱部14に弁形成部12を一体化させる上で好都合な構成となる。
Since the diagonal connecting members 18a and 18b are arranged so as not to cross each other connecting member 18, it is possible to avoid the gaps 23 formed between the column members 17 from being remarkably reduced. . In this case, the configuration is convenient when the valve forming portion 12 is integrated with the column portion 14 using the gap 23.
弁形成部12を、人体の組織体によってステント11全体を覆う(埋設させる)ように形成したため、人工弁10を体内に留置した状態においてステント11が体内の管壁に直接接触するのを回避することができる。これにより、血栓症等の症状が発生するのを防止することができる。
Since the valve forming portion 12 is formed so as to cover (embed) the entire stent 11 with a tissue of a human body, the stent 11 is prevented from directly contacting the tube wall in the body in a state where the artificial valve 10 is placed in the body. be able to. Thereby, it is possible to prevent the occurrence of symptoms such as thrombosis.
〔第2の実施形態〕
本実施形態では、ステント付き人工弁を構成するステントの構成が第1の実施形態とは相違する。以下、本実施形態におけるステント付き人工弁の構成について図6及び図7に基づいて説明する。図6は本実施形態におけるステントを示す斜視図であり、図7はそのステントを展開した状態で示す展開図である。なお、図6及び図7ではそれぞれステントの拡張状態を示している。 [Second Embodiment]
In the present embodiment, the configuration of the stent that constitutes the prosthetic valve with a stent is different from that of the first embodiment. Hereinafter, the configuration of the prosthetic valve with a stent in the present embodiment will be described with reference to FIGS. 6 and 7. FIG. 6 is a perspective view showing a stent in the present embodiment, and FIG. 7 is a development view showing the stent in a developed state. 6 and 7 each show an expanded state of the stent.
本実施形態では、ステント付き人工弁を構成するステントの構成が第1の実施形態とは相違する。以下、本実施形態におけるステント付き人工弁の構成について図6及び図7に基づいて説明する。図6は本実施形態におけるステントを示す斜視図であり、図7はそのステントを展開した状態で示す展開図である。なお、図6及び図7ではそれぞれステントの拡張状態を示している。 [Second Embodiment]
In the present embodiment, the configuration of the stent that constitutes the prosthetic valve with a stent is different from that of the first embodiment. Hereinafter, the configuration of the prosthetic valve with a stent in the present embodiment will be described with reference to FIGS. 6 and 7. FIG. 6 is a perspective view showing a stent in the present embodiment, and FIG. 7 is a development view showing the stent in a developed state. 6 and 7 each show an expanded state of the stent.
本実施形態における人工弁30(図8参照)は、ステント31と、ステント31によって保持される弁形成部32とを備える。弁形成部32は、第1の実施形態における弁形成部12と基本的に同じ構成であるため、ここでは詳細な説明を割愛する。簡単に説明すると、弁形成部32は、弁形成部12と同様、人体の組織体によってステント31を覆うように形成されており、筒状部33と、筒状部33の内周側に設けられる複数の弁膜(図示略)とを有している。図7では便宜上、弁形成部32のうち筒状部33だけを一点鎖線で図示している。
The artificial valve 30 (see FIG. 8) in the present embodiment includes a stent 31 and a valve forming portion 32 held by the stent 31. Since the valve formation part 32 is fundamentally the same structure as the valve formation part 12 in 1st Embodiment, detailed description is omitted here. Briefly, the valve forming part 32 is formed so as to cover the stent 31 with a human tissue like the valve forming part 12, and is provided on the inner peripheral side of the cylindrical part 33 and the cylindrical part 33. A plurality of valve membranes (not shown). In FIG. 7, for convenience, only the tubular portion 33 of the valve forming portion 32 is illustrated by a one-dot chain line.
図6及び図7に示すように、ステント31は、複数の線状要素によって全体として管状(円管状)に形成されている。ステント31は、弾性を有する金属材料により形成されており、具体的には超弾性合金の一種であるニッケルチタン(Ni-Ti)合金により形成されている。ステント31は、自らの弾性によって収縮状態から拡張状態へと変形するいわゆる自己拡張型のステントとなっている。なお、ステント31は、Au―Cd合金、Cu―Al-Ni合金又はNi―Ti―Co合金等といった他の超弾性合金により形成されてもよい。
As shown in FIGS. 6 and 7, the stent 31 is formed into a tubular shape (circular tubular shape) as a whole by a plurality of linear elements. The stent 31 is formed of a metal material having elasticity, and specifically, is formed of a nickel titanium (Ni—Ti) alloy which is a kind of superelastic alloy. The stent 31 is a so-called self-expanding stent that is deformed from a contracted state to an expanded state by its own elasticity. The stent 31 may be formed of another superelastic alloy such as an Au—Cd alloy, a Cu—Al—Ni alloy, or a Ni—Ti—Co alloy.
ステント31は、軸線方向に延びるとともに周方向に並んで設けられた複数(具体的には3つ)の柱部34と、周方向に隣り合う柱部34同士を互いに連結する複数の連結部35と、各柱部34における軸線方向の両端側に設けられた一対の保持部36,37とを備える。柱部34は、軸線方向に延びるとともに周方向に並んで設けられた一対の柱材38と、それら各柱材38同士を繋ぐ複数の繋ぎ材39とを有している。柱材38と繋ぎ材39とはいずれも線状要素により形成されている。
The stent 31 extends in the axial direction and is arranged side by side in the circumferential direction, and a plurality of (specifically three) column portions 34 and a plurality of coupling portions 35 that couple the circumferential column portions 34 to each other. And a pair of holding portions 36 and 37 provided on both end sides of each column portion 34 in the axial direction. The column portion 34 includes a pair of column members 38 that extend in the axial direction and are arranged in the circumferential direction, and a plurality of connecting members 39 that connect the column members 38 to each other. Both the column member 38 and the connecting member 39 are formed of linear elements.
連結部35は、線状要素によって周方向に延びる波線状に形成されている。連結部35は、周方向の両端部が隣り合う柱部34における当該周方向に互いに近い側の各柱材38にそれぞれ連結されている。連結部35は、各柱部34間ごとにそれぞれ配置され、それら各連結部35が周方向に1列に並んで配置されている。なお、連結部35の列は必ずしも1列とすることは必要なく、2列以上であってもよい。
The connecting portion 35 is formed in a wavy line extending in the circumferential direction by a linear element. The connecting portions 35 are respectively connected to the column members 38 on the sides close to each other in the circumferential direction in the column portions 34 whose both ends in the circumferential direction are adjacent to each other. The connection part 35 is arrange | positioned for every between each pillar part 34, respectively, and these each connection part 35 is arrange | positioned along with the circumferential direction at 1 row. In addition, the row | line | column of the connection part 35 does not necessarily need to be 1 row, and may be 2 or more rows.
保持部36は、各柱部34における軸線方向の一方側の端部に設けられ、保持部37は、各柱部34における軸線方向の他方側の端部に設けられている。これら各保持部36,37は、人工弁30が体内に留置された際に体内の管壁に押し付けられることでステント31(ひいては人工弁30)を保持する部分となっている。各保持部36,37はいずれも線状要素によって形成されている。
The holding portion 36 is provided at one end portion in the axial direction of each column portion 34, and the holding portion 37 is provided at the other end portion in the axial direction in each column portion 34. Each of the holding portions 36 and 37 is a portion that holds the stent 31 (and thus the artificial valve 30) by being pressed against the tube wall in the body when the artificial valve 30 is placed in the body. Each of the holding portions 36 and 37 is formed by a linear element.
保持部36は、周方向に隣り合う柱部34における軸線方向の一方側の端部同士を連結する連結部41を有する。連結部41は、隣り合う柱部34における周方向に互いに近い側の各柱材38同士を連結している。連結部41は、隣り合う柱部34間ごとにそれぞれ設けられ、それら各連結部41が周方向に並んで配置されている。なお、図6及び図7では、連結部41が各柱部34間ごとにそれぞれ2つずつ設けられているが、1つずつ又は3つ以上ずつ設けられていてもよい。
The holding portion 36 includes a connecting portion 41 that connects the end portions on one side in the axial direction of the column portions 34 adjacent in the circumferential direction. The connecting portion 41 connects the column members 38 on the sides close to each other in the circumferential direction in the adjacent column portions 34. The connecting portions 41 are respectively provided between adjacent column portions 34, and the connecting portions 41 are arranged side by side in the circumferential direction. 6 and 7, two connecting portions 41 are provided for each column portion 34, but may be provided one by one or three or more.
各連結部41はそれぞれ柱部34よりも軸線方向の一方側に延びており、その一方側の端部において他方側に折り返された折り返し形状を有している。各連結部41は、当該一方側に向かうにつれて径方向外側に変位するように形成されており、その一方側の端部では柱部34よりも径方向外側に位置している。したがって、保持部36は、全体として当該一方側の端部に向けて拡がるフレア状をなしている。なお、図6では便宜上、保持部36をフレアさせない状態で図示している(保持部37も同様)。
Each connecting portion 41 extends to one side in the axial direction from the column portion 34 and has a folded shape that is folded to the other side at an end portion on one side. Each connecting portion 41 is formed so as to be displaced radially outward as it goes to the one side, and is located radially outside the column portion 34 at the end portion on the one side. Accordingly, the holding portion 36 has a flare shape that expands toward the end portion on the one side as a whole. In FIG. 6, for convenience, the holding unit 36 is illustrated in a state where it is not flare (the holding unit 37 is also the same).
一方、保持部37は、各柱部34及び各連結部35よりも軸線方向の他方側に設けられており、ステント31の軸線を中心とする環状(円環状)でかつ波線状をなしている。保持部37は、各柱部34及び各連結部35にそれぞれ線状の中間材43を介して連結されている。保持部37は、軸線方向の他方側に向かうにつれて径方向外側に変位するように形成されており、当該他方側の端部では柱部34よりも径方向外側に位置している。したがって、保持部37は、全体として当該他方側の端部に向けて拡がるフレア状をなしている。なお、図6及び図7では、保持部37が1つだけ設けられているが、保持部37を軸線方向に所定間隔で複数(2つ以上)設けてもよい。また、保持部37の数、連結部41の数、連結部35の列数は、ステント31において目的とする拡張性能が得られる範囲であれば任意に設定してよい。
On the other hand, the holding portion 37 is provided on the other side in the axial direction with respect to each column portion 34 and each connecting portion 35, and has an annular shape (annular shape) around the axis of the stent 31 and has a wavy shape. . The holding portion 37 is connected to each column portion 34 and each connecting portion 35 via a linear intermediate member 43. The holding part 37 is formed so as to be displaced radially outward as it goes to the other side in the axial direction, and is located radially outside the column part 34 at the other end. Therefore, the holding portion 37 has a flare shape that expands toward the other end portion as a whole. 6 and 7, only one holding portion 37 is provided, but a plurality (two or more) holding portions 37 may be provided at predetermined intervals in the axial direction. Further, the number of holding portions 37, the number of connecting portions 41, and the number of rows of connecting portions 35 may be arbitrarily set as long as the target expansion performance can be obtained in the stent 31.
続いて、柱部34について詳しく説明する。
Subsequently, the column portion 34 will be described in detail.
柱部34には、繋ぎ材39として、軸線方向に対して所定の側に傾斜して延びる斜め繋ぎ材39aと、軸線方向に対して直交する方向に延びる直交繋ぎ材39bとがそれぞれ複数ずつ設けられている。斜め繋ぎ材39aと直交繋ぎ材39bとは軸線方向に交互に並んで配置され、隣り合う斜め繋ぎ材39aと直交繋ぎ材39bとが互いの端部同士で連結されている。これにより、斜め繋ぎ材39aと直交繋ぎ材39bとが軸線方向にジグザグ状に連続している。また、隣り合う斜め繋ぎ材39aと直交繋ぎ材39bとは、それら両者が連結し合う互いの端部にて柱材38と連結されている。これにより、斜め繋ぎ材39aと直交繋ぎ材39bと柱材38とによるトラスが軸線方向に連続して形成されている。なおここで、斜め繋ぎ材39aが第1繋ぎ材に相当し、直交繋ぎ材39bが第2繋ぎ材に相当する。
The column part 34 is provided with a plurality of oblique connecting members 39a extending obliquely to a predetermined side with respect to the axial direction and a plurality of orthogonal connecting members 39b extending in a direction orthogonal to the axial direction as connecting members 39. It has been. The oblique connecting members 39a and the orthogonal connecting members 39b are alternately arranged in the axial direction, and the adjacent oblique connecting members 39a and the orthogonal connecting members 39b are connected to each other at their ends. Thereby, the diagonal connecting material 39a and the orthogonal connecting material 39b are continuously zigzag in the axial direction. Further, the adjacent diagonal connecting member 39a and the orthogonal connecting member 39b are connected to the column member 38 at the end portions where they are connected to each other. Thereby, the truss by the diagonal connection material 39a, the orthogonal connection material 39b, and the pillar material 38 is formed continuously in the axial direction. Here, the diagonal connecting material 39a corresponds to the first connecting material, and the orthogonal connecting material 39b corresponds to the second connecting material.
直交繋ぎ材39bは、柱部34を挟んで周方向に隣り合う連結部35の間ごとにそれぞれ配置され、また柱部34を挟んで周方向に隣り合う連結部41の間ごとにそれぞれ配置されている。これらの直交繋ぎ材39bは、柱部34の各柱材38のうち一方の柱材38における連結部35(41)との連結箇所と、他方の柱材38における連結部35(41)との連結箇所とを互いに繋ぐように設けられている。また、一対の柱材38間において隣り合う繋ぎ材39a,39b同士の間には所定の隙間45が形成されている。
The orthogonal connecting members 39b are respectively disposed between the connecting portions 35 adjacent in the circumferential direction with the pillar portion 34 interposed therebetween, and are respectively disposed between the connecting portions 41 adjacent in the circumferential direction with the pillar portion 34 interposed therebetween. ing. These orthogonal connecting members 39b are connected to the connecting portion 35 (41) in one column member 38 and the connecting portion 35 (41) in the other column member 38 among the column members 38 of the column portion 34. It is provided so that a connection location may be connected mutually. A predetermined gap 45 is formed between the connecting members 39a and 39b adjacent to each other between the pair of column members 38.
以上がステント31についての説明である。
This completes the description of the stent 31.
上記ステント31に対して弁形成部32は当該ステント31と同軸に配置されており、その筒状部33が軸線方向においてステント31の各柱部34の全域に亘るように形成されている。筒状部33の内部にはステント31の各柱部34と各連結部35とがそれぞれ埋設されており、これによって筒状部33が各柱部34及び各連結部35と一体化されている。この場合、柱部34では、筒状部33の組織体の一部が当該柱部34の各隙間45に入り込んでおり、その隙間45に入り込んだ組織体が当該柱部34をその(表裏)両側からそれぞれ覆う組織体同士を互いに繋いでいる。そのため、筒状部33は、各柱部34に対して比較的強固に一体化されている。また、ステント31の各保持部36,37はそれぞれ筒状部33から軸線方向両側に露出した状態となっている。
The valve forming part 32 is arranged coaxially with the stent 31 with respect to the stent 31, and the cylindrical part 33 is formed so as to extend over the entire area of each column part 34 of the stent 31 in the axial direction. Each cylindrical portion 34 and each connecting portion 35 of the stent 31 are embedded in the cylindrical portion 33, and thereby the cylindrical portion 33 is integrated with each column portion 34 and each connecting portion 35. . In this case, in the column part 34, a part of the structure body of the cylindrical part 33 has entered each gap 45 of the column part 34, and the structure body that has entered the gap 45 has the column part 34 as its (front and back). Tissues covering each side are connected to each other. Therefore, the cylindrical portion 33 is relatively firmly integrated with each column portion 34. The holding portions 36 and 37 of the stent 31 are exposed from the cylindrical portion 33 on both sides in the axial direction.
なお、弁形成部32の弁膜については図示を省略しているが、弁膜は、隣り合う弁膜同士の境界部が周方向においてステント31の各柱部34と同位置に位置するよう配置され、当該境界部において柱部34と一体化されている。
Although the illustration of the valve membrane of the valve forming portion 32 is omitted, the valve membrane is arranged so that the boundary portion between adjacent valve membranes is located at the same position as each column portion 34 of the stent 31 in the circumferential direction. It is integrated with the column part 34 in the boundary part.
次に、人工弁30を疾患のある大動脈弁の置換弁として体内に留置する場合の様子について図8を用いながら説明する。図8は、人工弁30が大動脈弁の置換弁として体内に留置された様子を説明するための説明図である。
Next, how the artificial valve 30 is placed in the body as a replacement valve for a diseased aortic valve will be described with reference to FIG. FIG. 8 is an explanatory diagram for explaining a state in which the artificial valve 30 is placed in the body as a replacement valve for the aortic valve.
本実施形態では、人工弁30を所定の留置部位まで搬送するに際し、専用のデリバリカテーテルを用いて搬送する。かかるデリバリカテーテルとしては例えば、内側チューブと外側チューブとの二重構造からなるものが挙げられる。この場合、当該カテーテルの先端側における内側チューブと外側チューブとの間に、人工弁30をステント31を収縮させた状態で配置し、その配置状態で人工弁30を留置部位まで搬送する。そして、搬送後、内側チューブの外周面に設けられたストッパで人工弁30の基端側への移動を規制しながら、外側チューブを基端側へ引き抜くことで、人工弁30を外側チューブから遠位側に導出させる。これにより、ステント31が自らの弾性によって収縮状態から拡張状態へと変形し、そのステント拡張状態で人工弁30が留置部位に留置される。
In this embodiment, when the artificial valve 30 is transported to a predetermined indwelling site, it is transported using a dedicated delivery catheter. An example of such a delivery catheter is a double catheter structure composed of an inner tube and an outer tube. In this case, the artificial valve 30 is disposed in a contracted state of the stent 31 between the inner tube and the outer tube on the distal end side of the catheter, and the artificial valve 30 is transported to the indwelling site in the disposed state. Then, after the conveyance, the artificial valve 30 is removed from the outer tube by pulling the outer tube to the proximal side while restricting the movement of the artificial valve 30 to the proximal side with a stopper provided on the outer peripheral surface of the inner tube. Derived to the position side. Thereby, the stent 31 is deformed from the contracted state to the expanded state by its own elasticity, and the artificial valve 30 is indwelled at the indwelling site in the stent expanded state.
続いて、人工弁30の留置状態について説明する。
Subsequently, the indwelling state of the artificial valve 30 will be described.
図8に示すように、人工弁30は、バルサルバ洞V2における所定の留置部位にステント31の保持部36を上側、保持部37を下側に向けて留置されている。人工弁30は、弁形成部32(筒状部33)が各冠動脈BV4,BV5の入口部よりも下方に位置するように配置され、これにより、筒状部33により各冠動脈BV4,BV5の入口部が塞がれてしまうことが回避されている。また、人工弁30の留置状態において、保持部36は自らの弾性によってバルサルバ洞VB2の管壁に押し付けられており、これによってステント31ひいては人工弁30が安定した状態で保持されている。
As shown in FIG. 8, the artificial valve 30 is placed at a predetermined placement site in the Valsalva sinus V2 with the holding part 36 of the stent 31 on the upper side and the holding part 37 on the lower side. The artificial valve 30 is disposed such that the valve forming portion 32 (cylindrical portion 33) is located below the inlet portions of the coronary arteries BV4 and BV5, whereby the cylindrical portion 33 causes the inlets of the coronary arteries BV4 and BV5. It is avoided that the part is blocked. Further, in the indwelling state of the artificial valve 30, the holding portion 36 is pressed against the tube wall of the Valsalva sinus VB2 by its own elasticity, thereby holding the stent 31 and the artificial valve 30 in a stable state.
以上、詳述した本実施形態の構成によれば、以下の優れた効果が得られる。
As described above, according to the configuration of this embodiment described in detail, the following excellent effects can be obtained.
ステント31の柱部34に、一対の柱材38を繋ぐ繋ぎ材39として、軸線方向に対して傾斜して延びる斜め繋ぎ材39aと、軸線方向に対して直交する方向に延びる直交繋ぎ材39bとを設けた。斜め繋ぎ材39aは、軸線方向への成分を含む所定方向に延びている。そのため、柱部34の各柱材38がそれぞれ各々の柱材38に連結された異なる連結部35,41によって、軸線方向への位置ずれを生じさせる向きに引っ張られた場合、その引張力に対して抵抗力を付与することができる。これにより、各柱材38の軸線方向への位置ずれを抑制することができ、その結果柱部34の変形を抑制することができる。そのため、体内において人工弁30を安定した状態で留置することが可能となる。
As a connecting member 39 for connecting a pair of column members 38 to the column portion 34 of the stent 31, an oblique connecting member 39a extending obliquely with respect to the axial direction, and an orthogonal connecting member 39b extending in a direction orthogonal to the axial direction, Was provided. The diagonal connecting member 39a extends in a predetermined direction including a component in the axial direction. Therefore, when each column member 38 of the column part 34 is pulled in a direction that causes a positional shift in the axial direction by different connecting portions 35 and 41 connected to the respective column members 38, Resistance. Thereby, position shift to the axial direction of each pillar material 38 can be controlled, and as a result, deformation of pillar part 34 can be controlled. Therefore, it becomes possible to place the artificial valve 30 in a stable state in the body.
繋ぎ材39として、斜め繋ぎ材39aに加え、直交繋ぎ材39bを設けたため、柱材38間に斜め繋ぎ材39aのみを設ける場合と比べ、柱材38間に繋ぎ材39を数多く配置することができる。そのため、柱部34の強度を好適に高めることができ、その結果柱部34の変形を好適に抑制することが可能となる。
As the connecting material 39, since the orthogonal connecting material 39b is provided in addition to the oblique connecting material 39a, a large number of connecting materials 39 can be arranged between the column members 38 as compared with the case where only the oblique connecting material 39a is provided between the column members 38. it can. Therefore, the strength of the column part 34 can be suitably increased, and as a result, the deformation of the column part 34 can be suitably suppressed.
柱部34の各柱材38のうち一方の柱材38における連結部35との連結箇所と、他方の柱材38における連結部35との連結箇所とが軸線方向において同位置に設定されている構成において、それら各連結箇所を繋ぐように直交繋ぎ材39bを設けた。この場合、柱部34を挟んで隣り合う連結部35同士を直交繋ぎ材39bを介して繋ぐことができるため、それら連結部35同士の位置ずれを抑制することができる。その結果、各連結部35が連結された柱材38同士の位置ずれ抑制効果を高めることができ、ひいては柱部34の変形を抑制する効果を高めることができる。
Of each column member 38 of the column part 34, the connection part with the connection part 35 in one column member 38 and the connection part with the connection part 35 in the other column member 38 are set at the same position in the axial direction. In the configuration, an orthogonal connecting member 39b is provided so as to connect these connecting portions. In this case, the connecting portions 35 adjacent to each other with the pillar portion 34 interposed therebetween can be connected via the orthogonal connecting member 39b, so that the positional deviation between the connecting portions 35 can be suppressed. As a result, the effect of suppressing the displacement between the column members 38 to which the respective connecting portions 35 are connected can be enhanced, and as a result, the effect of suppressing the deformation of the column portions 34 can be enhanced.
繋ぎ材39として、斜め繋ぎ材39aと直交繋ぎ材39bとをそれぞれ複数ずつ設けるとともに、斜め繋ぎ材39aと直交繋ぎ材39bとを軸線方向に交互に並べて配置し互いの端部同士で連結することで連続させた。この場合、柱部34に、斜め繋ぎ材39aと直交繋ぎ材39bと柱材38とによるトラスを軸線方向に連続して形成することができるため、柱部34を極めて強固にすることができる。これにより、柱部34の変形を顕著に抑制することができ、人工弁30の留置状態を著しく安定なものとすることができる。
A plurality of oblique connecting members 39a and orthogonal connecting members 39b are provided as connecting members 39, and the oblique connecting members 39a and the orthogonal connecting members 39b are alternately arranged in the axial direction and connected to each other at the ends. It was continued with. In this case, since the truss made of the diagonal connecting member 39a, the orthogonal connecting member 39b, and the column member 38 can be continuously formed in the axial direction on the column portion 34, the column portion 34 can be extremely strengthened. Thereby, a deformation | transformation of the pillar part 34 can be suppressed notably and the indwelling state of the artificial valve 30 can be made extremely stable.
斜め繋ぎ材39aを、他の繋ぎ材39と互いに交差しないように配置したため、各柱材38間においてそれら両者間に形成される隙間45が著しく小さくなってしまうのを回避することができる。この場合、隙間45を利用して柱部34に弁形成部32を一体化させる上で好都合な構成となる。
Since the diagonal connecting members 39a are arranged so as not to intersect with the other connecting members 39, it is possible to avoid the gap 45 formed between the column members 38 from being remarkably reduced. In this case, the configuration is advantageous in integrating the valve forming portion 32 with the column portion 34 using the gap 45.
〔他の実施形態〕
本発明は上記実施形態に限らず、例えば次のように実施されてもよい。 [Other Embodiments]
The present invention is not limited to the above embodiment, and may be implemented as follows, for example.
本発明は上記実施形態に限らず、例えば次のように実施されてもよい。 [Other Embodiments]
The present invention is not limited to the above embodiment, and may be implemented as follows, for example.
(1)上記第1の実施形態において、一対の柱材17間に、繋ぎ材18として斜め繋ぎ材18a,18bのみを設けるようにしてもよい。つまり、直交繋ぎ材18cを不具備としてもよい。この場合にも、斜め繋ぎ材18a,18bが設けられていることで、各柱材17を軸線方向へ位置ずれさせようとする引張力に対し抵抗力を付与することができる。そのため、柱部14の変形を抑制することができ、人工弁10を安定した状態で留置することが可能となる。
(1) In the first embodiment, only the diagonal connecting members 18 a and 18 b may be provided as the connecting member 18 between the pair of pillar members 17. That is, the orthogonal connecting member 18c may be omitted. Also in this case, by providing the diagonal connecting members 18a and 18b, a resistance force can be applied to a tensile force that attempts to shift the position of each column member 17 in the axial direction. Therefore, the deformation of the column portion 14 can be suppressed, and the artificial valve 10 can be placed in a stable state.
また、上記第2の実施形態においても、これと同様に、一対の柱材38間に、繋ぎ材39として、斜め繋ぎ材のみを設けるようにしてもよい。すなわち、繋ぎ材39として、斜め繋ぎ材39aと、軸線方向に対して斜め繋ぎ材39aとは逆側に傾斜して延びる斜め繋ぎ材とのみを設けるようにしてもよい。
Also in the second embodiment, only the diagonal connecting material may be provided as the connecting material 39 between the pair of column members 38 in the same manner. That is, as the connecting material 39, only the oblique connecting material 39a and the oblique connecting material extending obliquely on the opposite side of the oblique connecting material 39a with respect to the axial direction may be provided.
(2)上記各実施形態において、斜め繋ぎ材18a,18b,39aと、他の繋ぎ材18,39とを互いの中間部で交差させて配置し、その交差部でそれら両者を連結するようにしてもよい。
(2) In each of the above embodiments, the diagonal connecting members 18a, 18b, 39a and the other connecting members 18, 39 are arranged so as to intersect each other, and the two are connected at the intersecting portion. May be.
(3)隣り合う繋ぎ材18,39同士を軸線方向に離間させて配置し、それら繋ぎ材18,39同士を非連結としてもよい。この場合、柱材17間に比較的大きな隙間23を形成することができるため、隙間23を利用して弁形成部12を一体化させるに際しより一層好都合となる。
(3) The adjacent connecting members 18 and 39 may be arranged apart from each other in the axial direction, and the connecting members 18 and 39 may be disconnected. In this case, since a relatively large gap 23 can be formed between the column members 17, it is even more convenient when the valve forming portion 12 is integrated using the gap 23.
(4)上記実施形態では、弁形成部12を、ステント11全体を覆うように形成したが、ステント11の一部だけを覆うように形成してもよい。その場合にも、人工弁10の留置状態においてステント11が体内の管壁に接触するのを抑制することができ、血栓症の発生を抑制することができる。
(4) In the above embodiment, the valve forming portion 12 is formed so as to cover the entire stent 11, but may be formed so as to cover only a part of the stent 11. Even in that case, the stent 11 can be prevented from coming into contact with the tube wall in the body in the indwelling state of the artificial valve 10, and the occurrence of thrombosis can be suppressed.
(5)弁形成部12は必ずしも自己の組織体により形成する必要はなく、他人の組織体により形成してもよい。この場合、ステント11を他人の体内に埋入しそのステント11周りに弁形成部12を形成させることとなる。また、弁形成部12を人以外の動物(異種動物)の組織体で形成してもよい。この場合、ステント11を異種動物の体内に埋入しそのステント11周りに弁形成部12を形成させることとなる。かかる異種動物としては例えば、ブタ、ウシ、ヤギ、イヌ、ウサギ等が挙げられる。なお、異種動物の組織体により弁形成部12を形成する場合には、脱細胞化処理を行うのが望ましい。
(5) The valve forming part 12 does not necessarily have to be formed by its own tissue body, but may be formed by another person's tissue body. In this case, the stent 11 is embedded in another person's body, and the valve forming part 12 is formed around the stent 11. Moreover, you may form the valve formation part 12 with the structure | tissue body of animals (heterogeneous animals) other than a person. In this case, the stent 11 is implanted in the body of a different animal, and the valve forming portion 12 is formed around the stent 11. Examples of such heterologous animals include pigs, cows, goats, dogs, rabbits and the like. In addition, when forming the valve formation part 12 with the tissue body of a different animal, it is desirable to perform a decellularization process.
上記実施形態では、ステント11を体内に埋入することでステント11周りに弁形成部12を一体形成したが、弁形成部12をステント11とは別体で形成してもよい。例えば、生体の体内に円柱状人工物(例えばマンドレル)を埋入することでその人工物周りに組織体を形成させ、その組織体により弁形成部を形成することが考えられる。この場合、弁形成部を、ステント11の各柱部14に隙間23を利用して縫合等することでステント11と一体化させることができる。
In the above embodiment, the valve forming portion 12 is integrally formed around the stent 11 by embedding the stent 11 in the body, but the valve forming portion 12 may be formed separately from the stent 11. For example, it is conceivable to form a tissue body around the artificial body by embedding a cylindrical artificial body (for example, a mandrel) in the body of the living body, and to form a valve forming portion by the tissue body. In this case, the valve forming portion can be integrated with the stent 11 by sewing or the like to each column portion 14 of the stent 11 using the gap 23.
また、弁形成部は、必ずしも生体の組織体により形成する必要はなく、高分子材料等他の材料で形成してもよい。その場合も、弁形成部を各柱部14に縫合等することでステント11と一体化させることができる。
Further, the valve forming part is not necessarily formed of a living body tissue, and may be formed of another material such as a polymer material. Also in that case, the valve forming portion can be integrated with the stent 11 by sewing or the like to each column portion 14.
(6)上記実施形態では、心臓の大動脈弁の置換弁として本発明のステント付き人工弁10を用いたが、心臓に設けられたその他の弁(心臓弁)、具体的には僧帽弁、三尖弁又は肺動脈弁の置換弁として用いることもできる。また、本発明の人工弁は必ずしも置換弁として用いる必要はなく、例えば血管内に留置して血管弁として用いるようにしてもよい。この場合、血液の逆流を抑制することで効率のよい血流を確保することが可能となる。また、血管以外の管内に留置してもよく、例えば食道に留置すれば逆流性食道炎の治療を行うことができる。
(6) In the above embodiment, the stented prosthetic valve 10 of the present invention is used as a replacement valve for the aortic valve of the heart, but other valves (heart valves) provided in the heart, specifically, mitral valves, It can also be used as a replacement valve for tricuspid or pulmonary valve. Further, the artificial valve of the present invention is not necessarily used as a replacement valve, and may be used as a vascular valve by being placed in a blood vessel, for example. In this case, efficient blood flow can be secured by suppressing the backflow of blood. Alternatively, it may be placed in a tube other than a blood vessel. For example, if it is placed in the esophagus, reflux esophagitis can be treated.
(7)ところで、人工弁10を大動脈弁の置換弁として体内に留置する際、当該人工弁10を図9(a)に示す向きで配置した場合と、図9(b)に示す向きで配置した場合とでは、X線投影下で前方からステント11の各柱部14を視認した際、各柱部14の位置がいずれの場合も同じ位置にあるように見えてしまうことが考えられる。そのため、人工弁10の留置に際し、人工弁10を各柱部14が冠動脈BV4,BV5の入口部と重複しない向き(すなわち図9(a)に示す向き)で配置したと思っていても、実際には各柱部14が冠動脈BV4,BV5の入口部と重複する向き(すなわち図9(b)に示す向き)で配置されていて当該入口部が柱部14の延出部19により塞がれていたといった事態が生ずることが考えられる。
(7) By the way, when the artificial valve 10 is placed in the body as a replacement valve for the aortic valve, the artificial valve 10 is arranged in the orientation shown in FIG. 9A and the orientation shown in FIG. 9B. In this case, when each column 14 of the stent 11 is visually recognized from the front under X-ray projection, it is considered that the position of each column 14 appears to be in the same position in any case. Therefore, when the artificial valve 10 is indwelled, even though it is assumed that the artificial valve 10 is arranged in such a direction that each column portion 14 does not overlap with the inlet portions of the coronary arteries BV4 and BV5 (that is, the direction shown in FIG. 9A) Each column 14 is arranged in a direction that overlaps with the inlet portions of the coronary arteries BV4 and BV5 (that is, the direction shown in FIG. 9B), and the inlet portions are blocked by the extending portions 19 of the column portions 14. It is conceivable that a situation such as that occurred.
そこで、この点に鑑みて、柱部14に、当該柱部14をステント11の径方向内側及び外側のうちいずれの側から見ているのかを判別するための識別表示部を設けてもよい。すなわち、柱部14に、径方向の外側から見た場合と、内側から見た場合とで見え方が異なる識別表示部を設けてもよい。具体的には、かかる識別表示部として、非対称形状からなる非対称マーカを設けることが考えられる。図10では、柱部14の延出部19に、かかる非対称マーカとして「G」の文字からなるマーカ48が設けられた構成が示されている。図10では、このマーカ48が径方向外側から見た場合に正しく見えるように設けられている。つまり、径方向内側から見た場合に、「G」の文字が反転して見えるように設けられている。なお、マーカ48は、柱部14において延出部19以外の部位に設けてもよい。
Therefore, in view of this point, the column portion 14 may be provided with an identification display unit for determining whether the column portion 14 is viewed from the radially inner side or the outer side of the stent 11. That is, the columnar portion 14 may be provided with an identification display portion that looks different when viewed from the outside in the radial direction and when viewed from the inside. Specifically, it is conceivable to provide an asymmetric marker having an asymmetric shape as the identification display unit. FIG. 10 shows a configuration in which a marker 48 made of a letter “G” is provided as an asymmetric marker on the extending portion 19 of the column portion 14. In FIG. 10, the marker 48 is provided so that it can be seen correctly when viewed from the outside in the radial direction. That is, it is provided so that the letter “G” appears to be reversed when viewed from the inside in the radial direction. The marker 48 may be provided at a portion other than the extending portion 19 in the column portion 14.
かかる構成によれば、人工弁10が図9(a)に示す向きで配置された場合には、正面の柱部14Aのマーカ48が正しく見え、図9(b)に示す向きで配置された場合には、正面の柱部14Aのマーカ48が反転して見えることとなる。この場合、体内における当該マーカ48の前後位置を把握することが可能となり、その結果人工弁10が図9(a)に示す向き又は図9(b)に示す向きのいずれの向きで配置されたのかを判別することが可能となる。これにより、人工弁10の留置に際し、柱部14(詳しくは延出部19)により冠動脈BV4,BV5の入口部を塞いでしまう事態を回避することが可能となる。
According to such a configuration, when the artificial valve 10 is arranged in the orientation shown in FIG. 9A, the marker 48 on the front pillar portion 14A looks correct and is arranged in the orientation shown in FIG. 9B. In this case, the marker 48 on the front pillar portion 14A appears to be reversed. In this case, it becomes possible to grasp the front-rear position of the marker 48 in the body, and as a result, the artificial valve 10 is arranged in either the direction shown in FIG. 9A or the direction shown in FIG. 9B. It is possible to determine whether or not. As a result, when the artificial valve 10 is indwelled, it is possible to avoid a situation where the inlet portions of the coronary arteries BV4 and BV5 are blocked by the column portion 14 (specifically, the extending portion 19).
10…人工弁、11…ステント、12…弁形成部、14…柱部、15…連結部、17…柱材、18…繋ぎ材、18a…第1斜め繋ぎ材、18b…第2斜め繋ぎ材、18c…直交繋ぎ材、19…延出部、30…人工弁、31…ステント、32…弁形成部、34…柱部、35…連結部、38…柱材、39…繋ぎ材、39a…斜め繋ぎ材、39b…直交繋ぎ材、48…識別表示部としてのマーカ。
DESCRIPTION OF SYMBOLS 10 ... Artificial valve, 11 ... Stent, 12 ... Valve formation part, 14 ... Column part, 15 ... Connection part, 17 ... Column material, 18 ... Connecting material, 18a ... 1st diagonal connection material, 18b ... 2nd diagonal connection material 18c ... Orthogonal connecting material, 19 ... Extension part, 30 ... Artificial valve, 31 ... Stent, 32 ... Valve forming part, 34 ... Column part, 35 ... Connecting part, 38 ... Column material, 39 ... Connecting material, 39a ... Oblique connecting material, 39b ... orthogonal connecting material, 48 ... marker as an identification display section.
Claims (9)
- 複数の線状要素によって管状に形成されるとともに、筒状部と該筒状部の内周側に設けられる複数の弁膜とを有する弁形成部を保持するための人工弁用のステントであって、
当該ステントの軸線方向に延びるとともに当該ステントの周方向に所定の間隔で配設され、かつ、前記筒状部とそれぞれ一体化される複数の柱部と、
前記周方向に隣り合う前記柱部同士を互いに連結する連結部と、
を備え、
前記柱部は、
前記軸線方向に延びるとともに前記周方向に並んで設けられた一対の柱材と、
それら各柱材同士を繋ぐ複数の繋ぎ材と、
を有しており、
前記一対の柱材のそれぞれには、前記周方向において異なる前記連結部が連結されており、
前記複数の繋ぎ材には、前記軸線方向に対して傾斜して延びる第1斜め繋ぎ材と、前記軸線方向に対して前記第1斜め繋ぎ材とは逆側に傾斜して延びる第2斜め繋ぎ材と、前記軸線方向に対して直交する方向に延びる直交繋ぎ材とのうち少なくともいずれか2つが含まれていることを特徴とするステント。 A stent for a prosthetic valve for holding a valve forming portion which is formed into a tubular shape by a plurality of linear elements and has a tubular portion and a plurality of valve membranes provided on the inner peripheral side of the tubular portion. ,
A plurality of pillars extending in the axial direction of the stent and arranged at predetermined intervals in the circumferential direction of the stent, and integrated with the cylindrical part,
A connecting portion that connects the column portions adjacent to each other in the circumferential direction;
With
The column portion is
A pair of pillars extending in the axial direction and arranged side by side in the circumferential direction;
A plurality of connecting materials that connect these pillar materials,
Have
Each of the pair of column members is connected to the different connecting portions in the circumferential direction,
The plurality of connecting members include a first oblique connecting member extending obliquely with respect to the axial direction, and a second oblique connecting member extending inclined to the opposite side of the first oblique connecting member with respect to the axial direction. A stent comprising at least any two of a material and an orthogonal connecting material extending in a direction orthogonal to the axial direction. - 前記複数の繋ぎ材には、前記直交繋ぎ材が含まれていることを特徴とする請求項1に記載のステント。 The stent according to claim 1, wherein the plurality of connecting members include the orthogonal connecting member.
- 前記複数の繋ぎ材には、前記直交繋ぎ材に加え、前記第1斜め繋ぎ材及び前記第2斜め繋ぎ材のうちいずれかの斜め繋ぎ材が含まれており、
前記直交繋ぎ材は、前記斜め繋ぎ材よりも太い線状要素により形成されていることを特徴とする請求項2に記載のステント。 In addition to the orthogonal joining material, the plurality of joining materials include any one of the first oblique joining material and the second oblique joining material,
The stent according to claim 2, wherein the orthogonal connecting material is formed by a linear element that is thicker than the oblique connecting material. - 前記柱部では、前記一対の柱材のうち一方の柱材における前記連結部との連結箇所と、他方の柱材における前記連結部との連結箇所とが前記軸線方向において同位置に設定されており、
前記直交繋ぎ材は、それら各連結箇所を繋ぐように設けられていることを特徴とする請求項2又は3に記載のステント。 In the column part, the connection part with the connection part in one column member of the pair of column members and the connection part with the connection part in the other column member are set at the same position in the axial direction. And
The stent according to claim 2 or 3, wherein the orthogonal connecting member is provided so as to connect the connecting portions. - 前記複数の繋ぎ材には、前記第1斜め繋ぎ材、前記第2斜め繋ぎ材及び前記直交繋ぎ材のうちのいずれか2つである第1繋ぎ材及び第2繋ぎ材がそれぞれ複数ずつ含まれており、
前記第1繋ぎ材と前記第2繋ぎ材とはそれぞれ前記軸線方向に交互に並ぶように配置され、それらの各端部となる位置で互いに連続するようにして接合されていることを特徴とする請求項1乃至4のいずれか一項に記載のステント。 The plurality of connecting members include a plurality of first connecting members and second connecting members that are any two of the first oblique connecting member, the second oblique connecting member, and the orthogonal connecting member. And
The first connecting material and the second connecting material are arranged so as to be alternately arranged in the axial direction, and are joined to each other at positions corresponding to the respective end portions thereof. The stent according to any one of claims 1 to 4. - 前記第1斜め繋ぎ材及び前記第2斜め繋ぎ材のうちいずれかの斜め繋ぎ材は、その中間部において他の繋ぎ材と互いに交差しないように配置されていることを特徴とする請求項1乃至5のいずれか一項に記載のステント。 The diagonal connecting material of any one of the first diagonal connecting material and the second diagonal connecting material is arranged so as not to intersect with other connecting materials at an intermediate portion thereof. The stent according to any one of 5.
- X線不透過性を有する材料により形成されているステントであり、
前記柱部には、前記ステントをX線投影下にて視認するに際し、当該柱部を前記ステントの径方向外側及び内側のうちいずれの側から見ているのかを判別するための識別表示部が設けられていることを特徴とする請求項1乃至6のいずれか一項に記載のステント。 A stent formed of a radiopaque material;
In the column part, when the stent is visually recognized under X-ray projection, an identification display unit for determining which side of the stent is viewed from the radially outer side or the inner side of the stent is provided. The stent according to any one of claims 1 to 6, wherein the stent is provided. - 請求項1乃至7のいずれか一項に記載されたステントと、
前記ステントによって保持された前記弁形成部と、
を備えるステント付き人工弁であって、
前記弁形成部は、生体の組織体によって前記ステントの少なくとも一部を埋設させるように形成されており、それによって前記ステントと一体化されていることを特徴とするステント付き人工弁。 A stent according to any one of claims 1 to 7;
The annuloplasty part held by the stent;
A prosthetic valve with a stent comprising:
The prosthetic valve with a stent, wherein the valve forming part is formed so as to embed at least a part of the stent by a living tissue, and thereby integrated with the stent. - 請求項1乃至7のいずれか一項に記載されたステントと、
前記ステントによって保持された前記弁形成部と、
を備えるステント付き人工弁であって、
前記弁形成部は、前記ステントの各柱部に対して一体化されており、
その一体化状態において前記各柱部にはそれぞれ前記筒状部よりも前記軸線方向に延出した延出部が設けられていることを特徴とするステント付き人工弁。 A stent according to any one of claims 1 to 7;
The annuloplasty part held by the stent;
A prosthetic valve with a stent comprising:
The valve forming part is integrated with each column part of the stent,
The prosthetic valve with a stent, wherein in each integrated state, each column part is provided with an extension part extending in the axial direction from the cylindrical part.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013010954A JP6010836B2 (en) | 2013-01-24 | 2013-01-24 | Stent and prosthetic valve with stent |
JP2013-010954 | 2013-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014115479A1 true WO2014115479A1 (en) | 2014-07-31 |
Family
ID=51227279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2013/084891 WO2014115479A1 (en) | 2013-01-24 | 2013-12-26 | Stent, and stent-equipped prosthetic valve |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6010836B2 (en) |
WO (1) | WO2014115479A1 (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004535240A (en) * | 2001-07-19 | 2004-11-25 | ザ クリーブランド クリニック ファウンデーション | Endovascular substitute having a biological tissue layer |
US20080154355A1 (en) * | 2006-12-22 | 2008-06-26 | Netanel Benichou | Implantable prosthetic valve assembly and method of making the same |
JP2010540079A (en) * | 2007-09-26 | 2010-12-24 | セント ジュード メディカル インコーポレイテッド | Foldable prosthetic heart valve |
JP2011500241A (en) * | 2007-10-25 | 2011-01-06 | サイメティス エスアー | Stent, valved stent and method, and delivery system thereof |
JP2011509805A (en) * | 2008-01-24 | 2011-03-31 | メドトロニック,インコーポレイテッド | Stent for prosthetic heart valve |
WO2011147849A1 (en) * | 2010-05-25 | 2011-12-01 | Jenavalve Technology Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
JP2012005846A (en) * | 2003-12-23 | 2012-01-12 | Sadra Medical Inc | Repositionable heart valve |
WO2012032187A1 (en) * | 2010-09-10 | 2012-03-15 | Symetis Sa | Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device |
JP2012528697A (en) * | 2009-06-05 | 2012-11-15 | メドトロニック エイティーエス メディカル インコーポレイテッド | Flexible commissure structure for attaching a bioprosthetic valve |
JP2012528691A (en) * | 2009-06-02 | 2012-11-15 | メドトロニック,インコーポレイテッド | Prosthetic heart valve with stent |
-
2013
- 2013-01-24 JP JP2013010954A patent/JP6010836B2/en active Active
- 2013-12-26 WO PCT/JP2013/084891 patent/WO2014115479A1/en active Application Filing
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004535240A (en) * | 2001-07-19 | 2004-11-25 | ザ クリーブランド クリニック ファウンデーション | Endovascular substitute having a biological tissue layer |
JP2012005846A (en) * | 2003-12-23 | 2012-01-12 | Sadra Medical Inc | Repositionable heart valve |
US20080154355A1 (en) * | 2006-12-22 | 2008-06-26 | Netanel Benichou | Implantable prosthetic valve assembly and method of making the same |
JP2010540079A (en) * | 2007-09-26 | 2010-12-24 | セント ジュード メディカル インコーポレイテッド | Foldable prosthetic heart valve |
JP2011500241A (en) * | 2007-10-25 | 2011-01-06 | サイメティス エスアー | Stent, valved stent and method, and delivery system thereof |
JP2011509805A (en) * | 2008-01-24 | 2011-03-31 | メドトロニック,インコーポレイテッド | Stent for prosthetic heart valve |
JP2012528691A (en) * | 2009-06-02 | 2012-11-15 | メドトロニック,インコーポレイテッド | Prosthetic heart valve with stent |
JP2012528697A (en) * | 2009-06-05 | 2012-11-15 | メドトロニック エイティーエス メディカル インコーポレイテッド | Flexible commissure structure for attaching a bioprosthetic valve |
WO2011147849A1 (en) * | 2010-05-25 | 2011-12-01 | Jenavalve Technology Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
WO2012032187A1 (en) * | 2010-09-10 | 2012-03-15 | Symetis Sa | Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device |
Also Published As
Publication number | Publication date |
---|---|
JP6010836B2 (en) | 2016-10-19 |
JP2014140520A (en) | 2014-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11026784B2 (en) | Stentless support structure | |
JP4510025B2 (en) | Implantable valve prosthesis | |
JP5491491B2 (en) | Stent prosthesis with selective flared crown | |
JP4739223B2 (en) | Implantable valve prosthesis | |
JP6479493B2 (en) | High flexibility stent | |
US7717952B2 (en) | Artificial prostheses with preferred geometries | |
US10792413B2 (en) | Implantable and removable customizable body conduit | |
US20190142590A1 (en) | Device for cardiac valve repair and method of implanting the same | |
CN103124537B (en) | Without rack supporting structure | |
JP2019511283A (en) | Guide extension catheter with helically shaped inlet port | |
JP2019520891A (en) | Guide extension catheter with grooved push member segment | |
JP2005525169A (en) | Method of making a medical device having a thin wall tubular membrane on a structural frame | |
JP5752658B2 (en) | Intraluminal medical device having axial flexibility that varies around | |
JP5902165B2 (en) | Flexible spiral stent with different spiral regions | |
JP5902164B2 (en) | Flexible helical stent with intermediate structural features | |
DE102008012438A1 (en) | Artificial heart valve for endovascular implantation of cardiac pacemaker and stent, for prosthetic replacement of aortic valve of e.g. young patient, has support structure connected with elastic membrane in region of edge of membrane | |
US20220241063A1 (en) | Aortic pressure loss reduction apparatus and methods | |
US9233012B2 (en) | Medical stent | |
JP6010836B2 (en) | Stent and prosthetic valve with stent | |
CN113855333A (en) | Split type valve support reaches intervention mitral valve replacement system including it | |
JP5960910B2 (en) | In-vivo indwelling delivery system | |
JP5914479B2 (en) | Flexible spiral stent with non-helical intermediate region |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13872985 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13872985 Country of ref document: EP Kind code of ref document: A1 |